US20070112591A1 - Generating a request from a nutraceutical inventory - Google Patents

Generating a request from a nutraceutical inventory Download PDF

Info

Publication number
US20070112591A1
US20070112591A1 US11/314,945 US31494505A US2007112591A1 US 20070112591 A1 US20070112591 A1 US 20070112591A1 US 31494505 A US31494505 A US 31494505A US 2007112591 A1 US2007112591 A1 US 2007112591A1
Authority
US
United States
Prior art keywords
canceled
inventory
partly based
registering
request quantity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/314,945
Inventor
Edward Jung
Royce Levien
Robert Lord
Mark Malamud
John Rinaldo
Clarence Tegreene
Lowell Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Searete LLC
Original Assignee
Searete LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/291,532 external-priority patent/US8532938B2/en
Priority claimed from US11/291,482 external-priority patent/US20070119928A1/en
Priority to US11/314,945 priority Critical patent/US20070112591A1/en
Application filed by Searete LLC filed Critical Searete LLC
Assigned to SEARETE LLC reassignment SEARETE LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LEVIEN, ROYCE A., RINALDO, JR., JOHN D., WOOD, JR., LOWELL L., JUNG, EDWARD K.Y., MALAMUD, MARK A, TEGREENE, CLARENCE T., LORD, ROBERT W.
Priority to US11/478,296 priority patent/US20070124218A1/en
Priority to US11/478,341 priority patent/US20070124219A1/en
Priority to US11/486,973 priority patent/US20070174128A1/en
Priority to US11/486,998 priority patent/US20070136092A1/en
Priority to US11/515,357 priority patent/US8340944B2/en
Priority to PCT/US2006/044658 priority patent/WO2007061835A2/en
Priority to PCT/US2006/047436 priority patent/WO2007078746A2/en
Priority to PCT/US2006/047451 priority patent/WO2008002322A2/en
Priority to EP06845313A priority patent/EP1964039A2/en
Priority to PCT/US2006/047835 priority patent/WO2007075378A2/en
Priority to EP06845489A priority patent/EP1964040A2/en
Publication of US20070112591A1 publication Critical patent/US20070112591A1/en
Priority to US11/824,604 priority patent/US20080004909A1/en
Priority to US11/824,529 priority patent/US10296720B2/en
Priority to US11/888,613 priority patent/US7827042B2/en
Priority to US11/893,608 priority patent/US7974856B2/en
Priority to US11/893,605 priority patent/US20080052114A1/en
Priority to US11/893,606 priority patent/US20080082272A1/en
Priority to US11/900,637 priority patent/US20080103746A1/en
Priority to US11/900,649 priority patent/US20080210748A1/en
Priority to US11/900,660 priority patent/US8068991B2/en
Priority to US11/977,174 priority patent/US8000981B2/en
Priority to US12/011,008 priority patent/US20080193919A1/en
Priority to US12/924,700 priority patent/US20110145009A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/40ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • G06Q10/08Logistics, e.g. warehousing, loading or distribution; Inventory or stock management
    • G06Q10/087Inventory or stock management, e.g. order filling, procurement or balancing against orders
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00Administration; Management
    • G06Q10/10Office automation; Time management
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06QINFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q30/00Commerce
    • G06Q30/06Buying, selling or leasing transactions
    • G06Q30/0601Electronic shopping [e-shopping]
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/20ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/20ICT specially adapted for the handling or processing of medical references relating to practices or guidelines

Definitions

  • the present application is related to, claims the earliest available effective filing date(s) from (e.g., claims earliest available priority dates for other than provisional patent applications; claims benefits under 35 USC ⁇ 119(e) for provisional patent applications), and incorporates by reference in its entirety all subject matter of the following listed application(s) (the “Related Applications”) to the extent such subject matter is not inconsistent herewith; the present application also claims the earliest available effective filing date(s) from, and also incorporates by reference in its entirety all subject matter of any and all parent, grandparent, great-grandparent, etc. applications of the Related Application(s) to the extent such subject matter is not inconsistent herewith.
  • Applicant entity understands that the statute is unambiguous in its specific reference language and does not require either a serial number or any characterization such as “continuation” or “continuation-in-part.” Notwithstanding the foregoing, applicant entity understands that the USPTO's computer programs have certain data entry requirements, and hence applicant entity is designating the present application as a continuation in part of its parent applications, but expressly points out that such designations are not to be construed in any way as any type of commentary and/or admission as to whether or not the present application contains any new matter in addition to the matter of its parent application(s).
  • An embodiment provides a method.
  • the method includes but is not limited to registering a nutraceutical-containing dispensation from an inventory and responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
  • related systems include but are not limited to circuitry and/or programming for effecting the herein referenced method aspects; the circuitry and/or programming can be virtually any combination of hardware, software, and/or firmware configured to effect the herein-referenced method aspects depending upon the design choices of the system designer.
  • An embodiment provides a system.
  • the system includes but is not limited to circuitry for registering a nutraceutical-containing dispensation from an inventory and a module for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
  • An embodiment provides another system.
  • the other system includes but is not limited to a computing device and one or more instructions that when executed by the computing device cause the computing device to perform at least one of registering a nutraceutical-containing dispensation from an inventory and responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
  • An embodiment provides a computer program product.
  • the computer program product includes but is not limited to a signal-bearing medium bearing at least one of (a) one or more instructions for registering a nutraceutical-containing dispensation from an inventory and (b) one or more instructions for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
  • FIG. 1 shows an operational flow representing example operations that produce an indication of an amount.
  • FIG. 2 shows an example system in schematic form, a hardware implementation able to perform variants of the flow of FIG. 1 .
  • FIG. 3 shows another example system able to perform the flow of FIG. 1 and many similar variations.
  • FIG. 4 shows another example system able to perform the flow of FIG. 1 and many similar variations.
  • FIG. 5 shows various optional features of the flow of FIG. 1 .
  • FIG. 6 shows another example system able to perform many variants of the above-described flows.
  • FIG. 7 shows various optional features of the flow of FIG. 1 or 5 .
  • FIG. 8 shows various optional features of the flow of FIG. 1, 5 , or 7 .
  • FIG. 9 shows further optional features of the system of FIG. 4 .
  • FIG. 10 shows various optional features of the flow of FIG. 1, 5 , 7 or 8 .
  • FIG. 11 shows a system that includes a signal-bearing medium that can comprise or interact with a conduit, a disk, an integrated circuit, or a computing device.
  • FIG. 12 shows other optional features of the above-described flows.
  • FIG. 13 shows still more optional features of the above-described flows.
  • FIG. 14 shows another example system embodiment in schematic form.
  • Nutraceutical bin 1445 can contain one or more nutraceuticals (e.g., nutraceutical-containing compounds) as well as medications and the like. Nutraceutical bin may comprise part of inventory manager 1444 , or may be situated in a stand-alone position accessible to user 1460 or one or more other users.
  • nutraceuticals e.g., nutraceutical-containing compounds
  • Nutraceutical bin may comprise part of inventory manager 1444 , or may be situated in a stand-alone position accessible to user 1460 or one or more other users.
  • FIG. 1 shows an operational flow 100 representing example operations that produce an indication of an amount of a request quantity, such as by indicating a rate or otherwise expressing a quantity that includes a nutraceutical.
  • Flow 100 and other embodiments as described below systemize regimens that include one or more of these components, facilitating or enabling a user's implementation of a regimen.
  • operational flow 100 moves to operation 140 , comprising registering a nutraceutical-containing dispensation from an inventory (e.g., registration logic 1440 receiving an indication that user 1460 has removed a certain quantity of nutraceutical from nutraceutrical bin 1445 ).
  • the dispensation can be a completed dispensation, an in-progress dispensation, a tentative dispensation, a scheduled dispensation, or a canceled dispensation of one or more nutraceutical-containing materials, for example.
  • the dispensation can relate to electronic inventory 1456 or any physical inventory.
  • flow 100 then moves to operation 150 , comprising responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen (e.g., quantity determination logic 1490 sending a request quantity via network interface 1492 —through network 1420 —to supplier system 1425 , where the request is partly based on a past or present content of nutraceutical bin 1445 and a partly based on a past or present consumption regimen as indicated by regimen description 1455 ).
  • the indication can be a display or other transmission, for example.
  • the consumption regimen can optionally contain one or more regimens or regimen components, such as seasonal, interspersed, contingent, occasional, or other conditional regimen(s).
  • the consumption regimen can comprise a component of a master regimen that also includes a non-consumption component.
  • FIGS. 5, 7 , 8 , 10 , 12 , and 13 below include many variations of operational flow 100 . In various embodiments such as these, of course, flow 100 can include additional operations or variations in the sequence of operations.
  • Primary module 210 includes circuitry 230 for receiving at least an indication of the registration (via linkage 232 , e.g.) of a state of a subject (an animal or other organism, e.g.).
  • Primary module 210 further includes logic 240 (such as a processor or programmable logic, e.g.) for indicating the request quantity (via interface 238 , e.g.) partly based on the dispensation or other aspect of the inventory, and partly based on the consumption regimen.
  • Primary module 210 can further include medium 250 accessible by at least logic 240 , as described below. (The dashed outline of medium 250 signifies that some embodiments are specifically contemplated to exclude this feature, and others are contemplated to include it.)
  • Linkage 232 is similarly indicated as optional. Even if system 200 is merely a kit or physical structure with no communication linkage 232 , for example, it can be advantageous for user 260 to access primary module 210 in proximity to inventory manager 280 .
  • Linkage 232 can include one or more of analog data, digital data, or a measurable physical property such as a distance or similar geometry.
  • linkage 232 can comprise a conduit bearing one or more instructions that can be stored in medium 250 , for example, or can be executed by logic 240 to perform one or more variations of flow 100 such as those shown in FIG. 5, 7 , 8 , 10 , 12 , or 13 .
  • information can be conveyed to primary module on a ticket or a similar printed record or memory device that can be deposited into primary module 210 .
  • circuitry 230 can receive information (such as the regimen, e.g.) remotely and/or from user 260 .
  • Inventory manager 280 includes a medication or other prescribed component (C 1 ) 281 , for example, and can include one or more nutraceutical-containing or other components (C 2 ) 282 .
  • Inventory manager 280 can be accessible to user 260 via optional interface 262 , which can optionally be used for receiving user input in lieu of interface 238 .
  • interface 262 can comprise a vending-machine-style dispenser able to dispense one or more of the component(s) 281 , 282 to user 260 .
  • primary module 210 can register the dispensation such as via linkage 232 or interface 238 , and respond accordingly (by operation 150 , e.g.).
  • System 300 includes circuitry 330 and logic 340 as described below, and can further include one or more of link 321 , interface 338 , or medium 350 .
  • Logic 340 can optionally receive input from a user (such as from user 360 via interface 338 , e.g.) locally.
  • Medium 350 can bear one or more instructions that can be executed by logic 340 (optionally a computing device, e.g.) for performing one or more of the flows of FIG. 5, 7 , 8 , 10 , 12 , or 13 .
  • link 321 can operably couple system 300 with network 320 .
  • network 320 can thus have access to online research resource 312 through linkage 322 or to server 313 through linkage 323 .
  • network 320 can have access to expert 314 through linkage 324 or to supplier 370 through linkage 327 .
  • Expert can actually be an herbalist, a pharmacist, a physician, a psychologist, a parent, an author, a document, a database, a blog, or any other source of opinion or information.
  • Research resource 312 can be remote from system 300 or from server 313 , expert 314 , or supplier 370 .
  • Expert 314 can optionally be located at a clinic or similar retail or healthcare facility that can advantageously include system 300 as well as one or more of online research resource 312 , server 313 , supplier 370 , or user 360 .
  • System 300 optionally includes circuitry (optionally circuitry 330 with link 321 , e.g.) for communicating with supplier 370 via network 320 , such as by electronic mail, facsimile, or a similar digital format.
  • circuitry 330 can coordinate with link 321 for communicating with a regimen server (such as server 313 , e.g.) or with a consultant (such as expert 314 ) remotely.
  • a regimen server such as server 313 , e.g.
  • consultant such as expert 314
  • supplier 370 can be configured to communicate with expert 314 via linkage 327 or with (another) user 360 via linkage 361 .
  • user 360 can access a component C 1 381 (and optionally one or more additional components C 2 382 ) in an inventory manager 380 via interface 362 .
  • system 300 is a computer or similar device with inventory maintenance capabilities.
  • logic 340 can register a dispensation from an inventory, for example by receiving an indication of the dispensation via user interface 338 .
  • Circuitry 330 can respond as appropriate by indicating a request quantity (at operation 150 , e.g.), such as by transmitting the request quantity via link 321 as an order (to supplier 370 , e.g.) or as a validation request (to a physician or other expert 314 , e.g.).
  • System 400 comprises circuitry 440 for registering a nutraceutical-containing dispensation from an inventory and module 470 for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
  • Circuitry 440 can adjoin, overlap, or otherwise be operable to interact with module 470 .
  • Module 470 optionally comprises circuitry 471 for determining the request quantity partly based on a user preference.
  • module 470 can comprise one or more of circuitry 472 for implementing the consumption regimen, medium 473 for storing at least the request quantity, circuitry 474 for confirming the nutraceutical-containing dispensation, or medium 475 bearing one or more instructions for generating the request quantity.
  • system 400 can further comprise circuitry 481 for receiving at least a portion of the consumption regimen remotely.
  • system 400 can further comprise circuitry 482 for identifying a compound comprising the request quantity, circuitry 483 for receiving a user preference, circuitry 484 for authenticating a user input, circuitry 485 for receiving an update of the consumption regimen, or circuitry 486 for receiving an update of the module for responding to the registering by indicating a request quantity.
  • Operation 140 may include one or more operations such as operation 543 , which depicts confirming the nutraceutical-containing dispensation (e.g., dispensation confirmation logic 1443 confirming that a user 1460 has removed about 6 grams of St. John's wort from nutraceutical bin 1445 over the course of a week, such as, for example, dispensation confirmation logic 1443 comparing starting and ending volumes of St. John's wort in nutraceutical bin 1445 ).
  • Operation 543 can likewise be performed by dispensation confirmation logic 1443 receiving a user input affirming the dispensation, for example, or by a module 470 that includes circuitry 474 of FIG. 4 .
  • user system 1400 of FIG. 14 or system 400 of FIG. 4 can alternatively or additionally be configured to perform operation 150 —responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen—by including one or more of operation 551 , operation 552 , operation 556 , operation 557 , operation 558 , or operation 560 .
  • Operation 551 comprises receiving a user preference (e.g., user interface 1462 receiving a preference from user 1460 that user 1460 desires a high-energy formulation of his regimen), such as can be performed by a system 400 that includes circuitry 483 of FIG. 4 .
  • Operation 552 comprises identifying a compound comprising the request quantity (e.g., compound identification logic 1496 identifying a nutraceutical such as bee pollen or ginkgo biloba). For example, if the electronic inventory 1456 indicates that the nutraceutical bin 1445 contains bee pollen and the user data 1454 indicates a preference for a high energy regimen, compound identification logic 1496 can identify bee pollen as a desirable nutraceutical by updating regimen description 1455 . In other embodiments, operation 552 can be performed a variant of system 400 that includes circuitry 482 .
  • Operation 556 comprises determining the request quantity partly based on a user preference (e.g., quantity determination logic 1490 determining that user 1460 has requested one pound of a protein supplement in response to a user preference for one-month-based purchases).
  • the user data 1454 can also include one or more preferences relating to nutraceutical price, freshness and/or diversity, or the like.
  • operation 556 can be performed by a module 470 that includes circuitry 471 of FIG. 4 .
  • Operation 557 comprises receiving the request quantity (e.g., user interface 1462 can receive data indicating a suggested amount of 50 tablets of a vitamin B complex), which can then be displayed to user 1460 or stored for later use, for example.
  • the request quantity can likewise be received from module 470 after executing the one or more instructions for generating the request quantity borne by medium 475 .
  • Operation 558 comprises storing the request quantity (e.g., user interface 1462 storing a message in user data 1454 containing several suggested reorder amounts until user 1460 logs in again).
  • operation 558 can be performed with medium 473 of FIG. 4 or with medium 350 of FIG. 3 .
  • These or other media of system 400 can likewise store data related to the request quantity, of course, such as other request quantities, medical history data, security information, supplier identification, user preferences, or instructions in light of teachings herein.
  • Operation 560 performing one or more additional operations—may include one or more of the following operations: 561 , 562 , 563 , 564 , and/or 566 .
  • Operation 561 depicts receiving an update of the consumption regimen remotely (e.g., network interface 1492 receiving an indication that a given expert's diet regimen now allows up to 280 grams of protein supplement per week). This information can then be used by scheduler 1483 or stored in regimen description 1455 for later display to user 1460 , for example.
  • Operation 562 depicts scheduling the consumption regimen (e.g., scheduler 1483 using a received update in changing the current regimen to allow at most 40 grams of protein per day).
  • operation 562 can be performed by a module 470 that includes circuitry 472 of FIG. 4 .
  • Operation 563 depicts receiving an update of a module (e.g., module update logic 1470 receiving version 2.7 of a data file relied upon by compound identification logic 1496 , and using it to replace version 2.8 previously in effect).
  • operation 563 can be performed by a system 400 that includes circuitry 486 of FIG. 4 .
  • Operation 564 depicts receiving at least a portion of the consumption regimen (e.g., network interface 1492 receiving a list of all 45 nutraceuticals that can be required by regimen X). User 1460 can use this information in determining whether regimen X will require any unusual purchases, for example. In other embodiments, operation 564 can be performed by circuitry 481 of FIG. 4 or by logic 240 of FIG. 2 , in some embodiments.
  • Operation 566 depicts authenticating a user input (e.g., authentication logic 1466 confirming the correctness of a password input by user 1460 ). In other embodiments, operation 566 can be performed by a system 400 that includes circuitry 484 of FIG. 4 .
  • System 600 can be configured to perform these variants with or without proximity or direct interaction with any user or inventory manager, except those few variants for which context dictates otherwise.
  • System 600 includes circuitry 650 for registering a dispensation from an inventory within a module 630 for responding to the registering by indicating a request, consistent with flow 100 of FIG. 1 .
  • module 630 can also include one or more of computing device 634 , logic 636 , or logic 638 .
  • Circuitry 650 can optionally include one or more of logic 654 , logic 656 , or memory 658 .
  • Storage 660 can optionally include one or more of code 667 , data 668 (which can comprise historical data or inventory data, e.g.), or other data 670 such as one or more regimens 672 , 674 .
  • logic 654 can comprise logic for prompting the test result (and/or other information that may relate to the subject) by requesting a test that partly depends on a medical history of the subject, for example, by transmitting a prompting signal as output 622 to network 620 . (See FIGS. 11&12 .)
  • system 600 can perform a flow 100 including an operation 556 , for example, based on a user preference received via input 621 and archived in storage 660 .
  • system 600 of FIG. 6 can optionally be configured to perform flow 100 with one or more of operation 743 or operation 749 .
  • Operation 743 comprises applying one or more inventory maintenance criteria to the inventory and to the nutraceutical-containing dispensation (e.g., inventory maintenance logic 1447 determining that a family's current regimen will exhaust the family's annis root in nutraceutical bin 1445 in less than a triggering time of two weeks).
  • the criteria can likewise include a default or user-specified upper limit on a monetary value of an inventory, for example, or a maximum acceptable age of a perishable nutraceutical-containing compound.
  • system 600 in response to receiving an input 621 indicating that a user's inventory manager is nearly full, for example, applying the criteria may accordingly reduce the request quantity to avoid spoilage, substantial investment in an ineffective or unneeded regimen, or other forms of waste.
  • system 600 optionally includes logic 638 comprising logic for querying a user responsive to the registering (at operation 749 ), such as by transmitting one or more requests as output 622 to network 620 . This approach can help tailor the regimen by seeking input about a subject when a user is likely to be available, for example, around the time of the registering.
  • Operation 749 comprises querying a user responsive to the registering (e.g., user query logic 1446 sending a request to user 1460 to know whether a child still has a flu, to facilitate a decision of whether to reorder).
  • Operation 754 comprises retrieving at least a portion of the consumption regimen at least partly based on one or more attributes of a primary subject (e.g., storage logic 1450 selecting a portion of the contents of regimen description 1455 based on learning that the primary subject is a 6′2′′ man who is slightly overweight).
  • operation 754 can include retrieving a regimen (regimen 672 of FIG. 6 , e.g.) unique to the subject. Absent such an individualized regimen, even a few attributes such as age or symptom can form a basis for an effective regimen.
  • Operation 755 comprises selecting the request quantity partly based on an increment size of an inventory (e.g., quantity determination logic 1490 deciding to suggest a second 1-pound tin of herbal tea even when 4 single-ounce packets would have been a less costly way to reach a total of 20 ounces).
  • data 668 of FIG. 6 may identify the increment size, for example, used by computing device 634 for performing the selecting operation 755 .
  • Operation 757 comprises receiving a user input indicating at least one of a nutraceutical or a symptom (e.g., compound identification logic 1496 receiving an indication of a symptom of “having foot cramps” from subject description 1453 or user 1460 ).
  • the user input may be received via a questionnaire (electronic or paper, e.g.), for example.
  • Operation 758 comprises selecting a nutraceutical at least partly based on one or more symptoms (e.g., compound identification logic 1496 selecting calcium and magnesium citrate responsive to an indication of foot cramps).
  • compound identification logic 1496 selecting calcium and magnesium citrate responsive to an indication of foot cramps.
  • system 200 of FIG. 2 or user system 1400 of FIG. 14 can be configured to perform flow 100 with operation 140 including one or more of operation 841 , operation 843 , operation 847 , operation 848 , or operation 849 .
  • Operation 841 comprises dispensing a nutraceutical (e.g., dispensation confirmation logic 1443 sending an instruction to nutraceutical bin 1445 or to user 1460 via display 1467 ).
  • inventory manager 280 likewise performs operation 841 , for example, by dispensing a nutraceutical-containing component 282 responsive to an instruction (via linkage 232 ) from primary module 210 .
  • the registering can optionally cause or enable or result from the dispensing operation 841 , or stand in some other relation to the dispensing operation 841 , conditional or otherwise.
  • Operation 843 comprises combining a mineral with an amino acid (e.g., regimen implementation logic 1480 implementing a nutraceutical combination including an amino acid chelated calcium).
  • an amino acid e.g., regimen implementation logic 1480 implementing a nutraceutical combination including an amino acid chelated calcium.
  • compound identification logic 1496 can optionally streamline regimen implementation by preferring multivitamins and other products that encapsulate more than one regimen component in a single article (tablet, e.g.) or otherwise consolidate consumption.
  • Operation 847 comprises registering a received antioxidant-containing component apportioned into one or more capsules (e.g., inventory maintenance logic 1447 receiving an electronic inventory update to show that vitamin C capsules have been added to nutraceutical bin 1445 ).
  • Operation 848 depicts allocating a multivitamin supplement component apportioned into one or more increments of a uniform increment size (e.g., inventory maintenance logic 1447 reserving all 100 identical tablets for the use of one person who draws from nutraceutical bin 1445 ).
  • Operation 849 comprises forming the nutraceutical-containing dispensation as a combination containing one or more of the capsules and one or more of the increments (e.g., inventory maintenance logic 1447 generating a dispensation specifying two capsules and one tablet, which dispensation can then be included in a message displayed to user 1460 ).
  • inventory maintenance logic 1447 generating a dispensation specifying two capsules and one tablet, which dispensation can then be included in a message displayed to user 1460 ).
  • FIG. 8 also shows various optional features of operational flow 100 of FIG. 1, 5 , or 7 comprising additional operation 852 , operation 854 , or operation 856 .
  • system 300 of FIG. 3 or user system 1400 of FIG. 4 can be configured to perform flow 100 with operation 150 including one or more of these additional operations.
  • Operation 852 comprises receiving a validation of at least a portion of the consumption regimen (e.g., network interface 1492 receiving a message of approval from the subject's doctor concerning a detoxifying regimen that includes calcium D-glucarate).
  • the validation of operation 852 can be received from user 360 or expert 314 , for example, optionally in response to an automated request for such a validation.
  • the request can define or justify the portion of the consumption regimen briefly, for example, and specify an action (such as clicking a button or entering a code, e.g.) by which the validation can be generated.
  • the responding operation 150 can optionally be made conditional on receiving the validation before a deadline, for example, or can otherwise affect a condition or manner by which system 300 will complete the responding operation 150 .
  • Operation 854 comprises receiving at least a portion of a health regimen that includes the consumption regimen (e.g., regimen description 1455 receiving a complete diet and exercise regimen).
  • the portion can be received by circuitry 330 via network 320 .
  • System 300 can present several such health regimens of interest to user 360 via interface 338 , for example, prompting user 360 to adopt one or more of the health regimens.
  • Logic 340 can then implement one or more user-adopted regimens by storing one or more instructions of each of the adopted regimens in medium 350 (a memory, e.g.).
  • system 300 can perform operation 856 before, during, after, or without the above-described adoption operation. See FIG. 10 , for example.
  • Operation 856 comprises receiving one or more components of the consumption regimen (e.g., regimen description 1455 receiving a complete diet and exercise regimen). Other components of the consumption regimen can optionally be obtained, for example, by deriving them from regimen description 1455 .
  • system 400 comprises circuitry 440 for registering a nutraceutical-containing dispensation from an inventory and module 470 for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
  • Module 470 optionally comprises display 971 configured for digitally indicating the request quantity.
  • module 470 can comprise one or more of display 972 configured for graphically indicating the request quantity, module 973 for receiving input from a user locally, or module 974 for predicting a state of the inventory.
  • module 470 can comprise signal-bearing medium 980 bearing one or more instructions such as those of FIG. 11 below.
  • system 400 can further comprise circuitry 981 for accessing a network.
  • system 400 can further comprise circuitry 982 for determining whether any update can be obtained for the consumption regimen, circuitry 983 for obtaining a regimen remotely, circuitry 984 for communicating with a consultant remotely, circuitry 985 for communicating with a supplier, or circuitry 986 for communicating with an inventory manager containing the inventory.
  • FIG. 10 there are shown various optional features of operational flow 100 of FIG. 1, 5 , 7 or 8 .
  • user system 1400 of FIG. 14 or system 400 of FIG. 9 can optionally be configured to perform flow 100 with operation 140 including one or more of operation 1041 , operation 1046 , operation 1047 , operation 1048 , or operation 1049 .
  • Operation 1041 comprises accessing a network (e.g., user query logic 1446 contacting a consultant or other user via the Internet).
  • operation 1041 is performed by circuitry 981 in the system 400 as shown in FIGS. 4 & 9 .
  • Operation 1047 comprises predicting a state of the inventory (e.g., event predictor 1448 predicting that a supply of zinc in nutraceutical bin 1445 will run out in 28 days in lieu of restocking or a regimen change).
  • operation 1047 can be performed by a variant of system 400 comprising module 974 .
  • the prediction may be based on one or more attributes of one or more dispensations such as the registered one(s), for example, or upon the consumption regimen or a current state of the inventory.
  • the predicted state may be detailed, such as a complete description of each component and its ingredients, its age, its location, and the like.
  • the predicted state may alternatively be more basic, such as “adequate” or “in need of component Z.”
  • the predicted state may also be expressed in various forms, such as a duration or a percentage.
  • Operation 1048 comprises postponing an action responsive to determining that the predicted state meets one or more criteria (e.g., scheduler 1483 postponing ordering any single item over $200 without a specific approval from user 1460 ).
  • scheduler 1483 postponing ordering any single item over $200 without a specific approval from user 1460 .
  • Operation 1049 comprises communicating with an inventory manager containing the inventory (e.g., dispensation confirmation logic 1443 or inventory maintenance logic 1447 communicating with inventory manager 1444 containing an inventory of supplements and medications in nutraceutical bin 1445 ).
  • an inventory manager containing the inventory e.g., dispensation confirmation logic 1443 or inventory maintenance logic 1447 communicating with inventory manager 1444 containing an inventory of supplements and medications in nutraceutical bin 1445 ).
  • Operation 1052 comprises determining whether any alternative, substitute, or other update can be obtained for the consumption regimen (e.g., module update logic 1470 reviewing an accumulation of content periodically within or through network interface 1492 to determine whether the Bone-UpTM regimen has published any updates since last month).
  • the determining can be performed by checking a mailbox, for example, or otherwise by sending a message into a network such as may be received by a server. Making a negative determination can be performed by receiving a negative reply or by waiting a given duration without receiving a reply, for example, or by making some similarly reasonable inference derived from one or more received signals.
  • Operation 1055 comprises graphically indicating the request quantity (e.g., display 1467 showing a pixel image of two bottles that can obviate a translation or enable a person to understand and approve a purchase without having to read).
  • display 972 performs operation 1055 by showing a first component that is visually distinguishable from at least a second component, such as by color or shape.
  • Operation 1056 comprises digitally indicating the request quantity (e.g., display 1467 showing a default reorder list to a nutraceutical vendor).
  • indicating operation 1056 can be performed by transmitting the request quantity digitally via a conduit (of FIG. 11 , e.g.) or a wireless link (of FIG. 3 , e.g.).
  • a system 1100 includes a signal-bearing medium 1180 that can comprise (or interact with) a conduit 1120 , a disk 1130 , an integrated circuit 1140 , or a computing device 1150 .
  • System 1100 can further include a dispenser 1170 .
  • Medium 1180 can optionally bear one or more instructions 1160 comprising at least one of (a) one or more instructions for registering a nutraceutical-containing dispensation from an inventory and (b) one or more instructions for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
  • medium 1180 can bear one or more instructions 1162 for recording the nutraceutical-containing dispensation with other medical history data of a subject.
  • the other medical history data can include one or more prior recordings of a dispensation, for example.
  • medium 1180 can bear one or more instructions 1163 for performing the nutraceutical-containing dispensation.
  • medium 1180 can bear one or more instructions 1164 for prompting the nutraceutical-containing dispensation.
  • medium 1180 can bear one or more instructions 1165 for detecting the nutraceutical-containing dispensation.
  • medium 1180 can bear one or more instructions 1166 for determining the request quantity.
  • medium 1180 can bear one or more instructions 1168 comprising at least one of (a) one or more instructions for receiving an indication of a quantity within each of one or more delivery units and (b) one or more instructions for indicating the request quantity as a number of the one or more delivery units.
  • a given set of one or more instructions can comprise more than one of instructions 1162 - 1168 , of course, optionally executable by computing device 1150 .
  • system 1100 of FIG. 11 can optionally be configured to perform flow 100 with operation 140 including one or more of operation 1242 , operation 1243 , operation 1246 , operation 1247 , or 1249 .
  • Operation 1243 comprises prompting the nutraceutical-containing dispensation (e.g., regimen implementation logic 1480 causing inventor manager 1444 to perform a physical dispensation immediately). This can likewise be performed by a computing device 1150 , for example, such as by transmitting a dispensing command or by otherwise causing an actuation of a dispenser.
  • a computing device 1150 for example, such as by transmitting a dispensing command or by otherwise causing an actuation of a dispenser.
  • Operation 1246 comprises detecting the nutraceutical-containing dispensation (e.g., dispensation confirmation logic 1443 detecting a physical dispensation from inventory manager 1444 or a planned dispensation from regimen implementation logic 1480 ).
  • operation 1246 can be performed by integrated circuit 1140 before, during, after, or without the physical dispensation.
  • the dispensation to be registered can optionally be conditional, scheduled, or actual.
  • Operation 1247 comprises responding to a result of a test indicating a state of a subject (e.g., user query logic 1446 receiving a “yes” response after asking the user 1460 whether the subject has a fever).
  • operation 1247 can be performed by executing one or more instructions 1166 for determining the request quantity.
  • Operation 1251 comprises displaying a performance indicator of the regimen relating to a potential result of following the regimen (e.g., display 1467 can show a comparison between a likelihood of catching a flu with a probiotic-containing yogurt regimen and a similar likelihood without a regimen).
  • the potential result can be tangible, intangible, subjective, objective, or some combination of these.
  • the performance ratio or other indicator can comprise an estimated probability of a measurable improvement, a ratio of “satisfied” regimen subscribers to “dissatisfied” regimen subscribers, a record of subjective experience, an anecdotal log, a rating, a research summary, a certification, an endorsement, or some other indicator.
  • Operation 1253 comprises receiving an indication of a quantity within each of one or more delivery units (e.g., electronic inventory 1456 including an indication of a per-unit “dose”).
  • the quantity can be a nominal increment of mass (such as milligrams of a vitamin, e.g.), a count (of eggs, e.g.), a length, or some other convenient increment.
  • a code module comprising one or more instructions 1166 performs operation 1253 before or during operation 1254 .
  • Operation 1254 comprises indicating the request quantity as a number of the one or more delivery units (e.g., regimen description 1455 describing a regimen as 2 units of item X, et cetera, with item X defined only in electronic inventory 1456 ).
  • regimen description 1455 describing a regimen as 2 units of item X, et cetera, with item X defined only in electronic inventory 1456 .
  • Operation 1255 comprises detecting a condition (e.g., quantity determination logic 1490 detecting a user login or other action via user interface 1462 ).
  • the condition can comprise a substantially periodic event, for example, such as an appointment, a day of the month, a time of day, a mealtime, a work break, or the like.
  • the condition can also comprise a storm or other weather condition, a job change or price change or other economic event, a smoking habit or some other personal condition, or any other condition that may affect the subject's life.
  • the detecting can be triggered by a signal from a calendar program, an alarm clock, a sensor, a network event, or a real time trigger, for example.
  • system 300 of FIG. 3 performs operation 150 responsive to one or more criteria that depend on the detected event(s) as well as the request quantity and the regimen.
  • a care provider can use system 300 to adjust or otherwise update a regimen-implementing request automatically, responsive to a scheduled visit by a patient, for example, if system 300 performs operation 1256 .
  • Operation 1258 comprises determining the request quantity partly based on an indication of a visible attribute or a behavior of a subject (e.g., compound identification logic 1496 and quantity determination logic 1490 identifying and ordering a quantity of non-prescription lithium responsive to chronic extreme mood swings).
  • the subject e.g., compound identification logic 1496 and quantity determination logic 1490 identifying and ordering a quantity of non-prescription lithium responsive to chronic extreme mood swings.
  • the subject a psychologist, a psychiatrist, a parent, or some other observer may provide an objective indication (conscious, e.g.), for example, or a subjective indication (irritable or fatigued, e.g.) of the attribute or behavior.
  • the request quantity may be zero if the visible attribute or the behavior indicates a negative reaction by the subject to a component of that regimen, for example.
  • the indication may relate to a facial attribute (“bags under the eyes,” e.g.), some other skin condition (“rash,” e.g.), or any other visible attribute of a subject.
  • Operation 1259 comprises indicating the request quantity via a display of a hand-held device (e.g., display 1467 indicating the quantity via a cell phone, a camera, or a hybrid device).
  • a display e.g., display 1467 indicating the quantity via a cell phone, a camera, or a hybrid device.
  • any of the above-described systems can optionally include a display, for example.
  • the system can comprise a hand-held device such as a cell phone, wrist watch or the like.
  • Operation 140 registering a nutraceutical-containing dispensation from an inventory—may include one or more of the following operations: 1341 , 1342 , 1343 , 1344 , or 1345 .
  • Operation 1341 depicts listing one or more nutraceuticals and one or more pharmaceuticals in the nutraceutical-containing dispensation (e.g., regimen implementation logic 1480 including these items in a displayed or transmitted dispensation).
  • Operation 1360 may include one or more of the following operations: 1361 , 1362 , 1363 , 1364 , 1366 , 1368 , or
  • Operation 1361 depicts receiving a request for a subscription (e.g., user interface 1462 receiving a decision that user 1460 is subscribing to the Adkins diet).
  • Operation 1362 depicts obtaining data from one or more remote sources (e.g., registration logic receiving the registration(s) as the obtained data from a nutraceutical bin 1445 that can be remote).
  • Operation 1363 depicts obtaining data via a network (e.g., network interface 1492 receiving data via the Internet).
  • the subject may be diagnosed as having an allergy to seafood, for example, which may bear against a fish oil supplement. Substantially the same criterion (“no fish,” e.g.) may effectively become a part of a given subject's regimen in other circumstances as well. It may arise from a received user instruction or preference (“no fish,” e.g.), a user status (“vegan,” e.g.), or otherwise arise from a received input (via interface 1462 , e.g.). The subject may be diagnosed with osteoporosis, as another example, which may bear toward a calcium-containing (or higher-calcium) regimen.
  • an implementer may opt for a mainly hardware and/or firmware vehicle; alternatively, if flexibility is paramount, the implementer may opt for a mainly software implementation; or, yet again alternatively, the implementer may opt for some combination of hardware, software, and/or firmware.
  • any vehicle to be utilized is a choice dependent upon the context in which the vehicle will be deployed and the specific concerns (e.g., speed, flexibility, or predictability) of the implementer, any of which may vary.
  • Those skilled in the art will recognize that optical aspects of implementations will typically employ optically-oriented hardware, software, and or firmware.
  • any two components herein combined to achieve a particular functionality can be seen as “associated with” each other such that the desired functionality is achieved, irrespective of architectures or intermedial components.
  • any two components so associated can also be viewed as being “operably connected,” or “operably coupled,” to each other to achieve the desired functionality.
  • operably couplable any two components capable of being so associated can also be viewed as being “operably couplable” to each other to achieve the desired functionality.
  • operably couplable include but are not limited to physically mateable and/or physically interacting components and/or wirelessly interactable and/or wirelessly interacting components and/or logically interactable and/or logically interacting components.

Abstract

A method, system, and computer program product are described for registering a nutraceutical-containing dispensation from an inventory and responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • The present application is related to, claims the earliest available effective filing date(s) from (e.g., claims earliest available priority dates for other than provisional patent applications; claims benefits under 35 USC § 119(e) for provisional patent applications), and incorporates by reference in its entirety all subject matter of the following listed application(s) (the “Related Applications”) to the extent such subject matter is not inconsistent herewith; the present application also claims the earliest available effective filing date(s) from, and also incorporates by reference in its entirety all subject matter of any and all parent, grandparent, great-grandparent, etc. applications of the Related Application(s) to the extent such subject matter is not inconsistent herewith. The United States Patent Office (USPTO) has published a notice to the effect that the USPTO's computer programs require that patent applicants reference both a serial number and indicate whether an application is a continuation or continuation in part. Stephen G. Kunin, Benefit of Prior-Filed Application, USPTO Electronic Official Gazette, Mar. 18, 2003 at http://www.uspto.gov/web/offices/com/sol/og/2003/week11/patbene.htm. The present applicant entity has provided below a specific reference to the application(s) from which priority is being claimed as recited by statute. Applicant entity understands that the statute is unambiguous in its specific reference language and does not require either a serial number or any characterization such as “continuation” or “continuation-in-part.” Notwithstanding the foregoing, applicant entity understands that the USPTO's computer programs have certain data entry requirements, and hence applicant entity is designating the present application as a continuation in part of its parent applications, but expressly points out that such designations are not to be construed in any way as any type of commentary and/or admission as to whether or not the present application contains any new matter in addition to the matter of its parent application(s).
  • Related Applications:
  • 1. For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of U.S. patent application Ser. No. 11/283,548, entitled PROVIDING ASSISTANCE RELATED TO HEALTH, naming Edward K. Y. Jung, Joyce A. Levien, Robert W. Lord, Mark A. Malamud, John D. Rinaldo, Jr., Clarence T. Tegreene and Lowell L. Wood, Jr. as inventors, filed Nov. 17, 2005, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • 2. For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of U.S. patent application Ser. No. 11/291,482, entitled TESTING-DEPENDENT ADMINISTRATION OF A NUTRACEUTICAL, naming Edward K. Y. Jung, Royce A. Levien, Robert W. Lord, Mark A. Malamud, John D. Rinaldo, Jr., Clarence T. Tegreene and Lowell L. Wood, Jr. as inventors, filed Nov. 30, 2005, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • 3. For purposes of the USPTO extra-statutory requirements, the present application constitutes a continuation-in-part of U.S. patent application Ser. No. 11/291,532, entitled GENERATING A NUTRACEUTICAL REQUEST FROM AN INVENTORY, naming Edward K. Y. Jung, Royce A. Levien, Robert W. Lord, Mark A. Malamud, John D. Rinaldo, Jr., Clarence T. Tegreene an dLowell L. Wood, Jr. as inventors, filed Nov. 30, 2005, which is currently co-pending, or is an application of which a currently co-pending application is entitled to the benefit of the filing date.
  • SUMMARY
  • An embodiment provides a method. In one implementation, the method includes but is not limited to registering a nutraceutical-containing dispensation from an inventory and responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen. In addition to the foregoing, other communication method aspects are described in the claims, drawings, and text forming a part of the present disclosure.
  • In one or more various aspects, related systems include but are not limited to circuitry and/or programming for effecting the herein referenced method aspects; the circuitry and/or programming can be virtually any combination of hardware, software, and/or firmware configured to effect the herein-referenced method aspects depending upon the design choices of the system designer.
  • An embodiment provides a system. In one implementation, the system includes but is not limited to circuitry for registering a nutraceutical-containing dispensation from an inventory and a module for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen. In addition to the foregoing, other computer program product aspects are described in the claims, drawings, and text forming a part of the present disclosure.
  • An embodiment provides another system. In one implementation, the other system includes but is not limited to a computing device and one or more instructions that when executed by the computing device cause the computing device to perform at least one of registering a nutraceutical-containing dispensation from an inventory and responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen. In addition to the foregoing, other computer program product aspects are described in the claims, drawings, and text forming a part of the present disclosure.
  • An embodiment provides a computer program product. In one implementation, the computer program product includes but is not limited to a signal-bearing medium bearing at least one of (a) one or more instructions for registering a nutraceutical-containing dispensation from an inventory and (b) one or more instructions for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
  • In addition to the foregoing, various other embodiments are set forth and described in the text (e.g., claims and/or detailed description) and/or drawings of the present description.
  • The foregoing is a summary and thus contains, by necessity, simplifications, generalizations and omissions of detail; consequently, those skilled in the art will appreciate that the summary is illustrative only and is not intended to be in any way limiting. Other aspects, features, and advantages of the devices and/or processes described herein, as defined by the claims, will become apparent in the detailed description set forth herein.
  • BRIEF DESCRIPTION OF THE FIGURES
  • FIG. 1 shows an operational flow representing example operations that produce an indication of an amount.
  • FIG. 2 shows an example system in schematic form, a hardware implementation able to perform variants of the flow of FIG. 1.
  • FIG. 3 shows another example system able to perform the flow of FIG. 1 and many similar variations.
  • FIG. 4 shows another example system able to perform the flow of FIG. 1 and many similar variations.
  • FIG. 5 shows various optional features of the flow of FIG. 1.
  • FIG. 6 shows another example system able to perform many variants of the above-described flows.
  • FIG. 7 shows various optional features of the flow of FIG. 1 or 5.
  • FIG. 8 shows various optional features of the flow of FIG. 1, 5, or 7.
  • FIG. 9 shows further optional features of the system of FIG. 4.
  • FIG. 10 shows various optional features of the flow of FIG. 1, 5, 7 or 8.
  • FIG. 11 shows a system that includes a signal-bearing medium that can comprise or interact with a conduit, a disk, an integrated circuit, or a computing device.
  • FIG. 12 shows other optional features of the above-described flows.
  • FIG. 13 shows still more optional features of the above-described flows.
  • FIG. 14 shows another example system embodiment in schematic form.
  • DETAILED DESCRIPTION
  • FIG. 14 shows user system 1400 comprising one or more of registration logic 1440 or quantity determination logic 1490. Quantity determination logic 1490 optionally comprises one or more of storage logic 1450, user interface 1462, module update logic 1470, network interface 1492, or compound identification logic 1496. Registration logic 1440 can include one or more of dispensation confirmation logic 1443, user query logic 1446, inventory maintenance logic 1447, event predictor 1448, regimen implementation logic 1480, or scheduler 1483. Storage logic 1450 can include one or more of subject description 1453, user data 1454, regimen description 1455, and electronic inventory 1456. User interface 1462 can include one or more of authentication logic 1466 or display 1467. Nutraceutical bin 1445 can contain one or more nutraceuticals (e.g., nutraceutical-containing compounds) as well as medications and the like. Nutraceutical bin may comprise part of inventory manager 1444, or may be situated in a stand-alone position accessible to user 1460 or one or more other users.
  • FIG. 1 shows an operational flow 100 representing example operations that produce an indication of an amount of a request quantity, such as by indicating a rate or otherwise expressing a quantity that includes a nutraceutical. Flow 100 and other embodiments as described below systemize regimens that include one or more of these components, facilitating or enabling a user's implementation of a regimen.
  • After a start operation, operational flow 100 moves to operation 140, comprising registering a nutraceutical-containing dispensation from an inventory (e.g., registration logic 1440 receiving an indication that user 1460 has removed a certain quantity of nutraceutical from nutraceutrical bin 1445). The dispensation can be a completed dispensation, an in-progress dispensation, a tentative dispensation, a scheduled dispensation, or a canceled dispensation of one or more nutraceutical-containing materials, for example. Likewise the dispensation can relate to electronic inventory 1456 or any physical inventory. After operation 140, flow 100 then moves to operation 150, comprising responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen (e.g., quantity determination logic 1490 sending a request quantity via network interface 1492—through network 1420—to supplier system 1425, where the request is partly based on a past or present content of nutraceutical bin 1445 and a partly based on a past or present consumption regimen as indicated by regimen description 1455). The indication can be a display or other transmission, for example. The consumption regimen can optionally contain one or more regimens or regimen components, such as seasonal, interspersed, contingent, occasional, or other conditional regimen(s). Alternatively or additionally, the consumption regimen can comprise a component of a master regimen that also includes a non-consumption component. FIGS. 5, 7, 8, 10, 12, and 13 below include many variations of operational flow 100. In various embodiments such as these, of course, flow 100 can include additional operations or variations in the sequence of operations.
  • Referring now to FIG. 2, there is shown an example system 200 in schematic form, a hardware implementation able to perform variants of flow 100 as described below. Primary module 210 includes circuitry 230 for receiving at least an indication of the registration (via linkage 232, e.g.) of a state of a subject (an animal or other organism, e.g.). Primary module 210 further includes logic 240 (such as a processor or programmable logic, e.g.) for indicating the request quantity (via interface 238, e.g.) partly based on the dispensation or other aspect of the inventory, and partly based on the consumption regimen. Primary module 210 can further include medium 250 accessible by at least logic 240, as described below. (The dashed outline of medium 250 signifies that some embodiments are specifically contemplated to exclude this feature, and others are contemplated to include it.)
  • Linkage 232 is similarly indicated as optional. Even if system 200 is merely a kit or physical structure with no communication linkage 232, for example, it can be advantageous for user 260 to access primary module 210 in proximity to inventory manager 280. Linkage 232 can include one or more of analog data, digital data, or a measurable physical property such as a distance or similar geometry. Alternatively or additionally, linkage 232 can comprise a conduit bearing one or more instructions that can be stored in medium 250, for example, or can be executed by logic 240 to perform one or more variations of flow 100 such as those shown in FIG. 5, 7, 8, 10, 12, or 13. Alternatively or additionally, information can be conveyed to primary module on a ticket or a similar printed record or memory device that can be deposited into primary module 210. Alternatively or additionally, circuitry 230 can receive information (such as the regimen, e.g.) remotely and/or from user 260.
  • Inventory manager 280 includes a medication or other prescribed component (C1) 281, for example, and can include one or more nutraceutical-containing or other components (C2) 282. Inventory manager 280 can be accessible to user 260 via optional interface 262, which can optionally be used for receiving user input in lieu of interface 238. Alternatively or additionally, interface 262 can comprise a vending-machine-style dispenser able to dispense one or more of the component(s) 281, 282 to user 260. Even in an embodiment in which dispensations are via a third party, and in lieu of interface 262, primary module 210 can register the dispensation such as via linkage 232 or interface 238, and respond accordingly (by operation 150, e.g.).
  • Referring now to FIG. 3, there is shown another example system 300 able to perform operational flow 100 of FIG. 1 and many similar variations. System 300 includes circuitry 330 and logic 340 as described below, and can further include one or more of link 321, interface 338, or medium 350. Logic 340 can optionally receive input from a user (such as from user 360 via interface 338, e.g.) locally. Medium 350 can bear one or more instructions that can be executed by logic 340 (optionally a computing device, e.g.) for performing one or more of the flows of FIG. 5, 7, 8, 10, 12, or 13.
  • As shown, link 321 can operably couple system 300 with network 320. In some embodiments, network 320 can thus have access to online research resource 312 through linkage 322 or to server 313 through linkage 323. Alternatively or additionally, network 320 can have access to expert 314 through linkage 324 or to supplier 370 through linkage 327. (“Expert” 314 can actually be an herbalist, a pharmacist, a physician, a psychologist, a parent, an author, a document, a database, a blog, or any other source of opinion or information.) Research resource 312 can be remote from system 300 or from server 313, expert 314, or supplier 370. Expert 314 can optionally be located at a clinic or similar retail or healthcare facility that can advantageously include system 300 as well as one or more of online research resource 312, server 313, supplier 370, or user 360.
  • System 300 optionally includes circuitry (optionally circuitry 330 with link 321, e.g.) for communicating with supplier 370 via network 320, such as by electronic mail, facsimile, or a similar digital format. Alternatively or additionally, circuitry 330 can coordinate with link 321 for communicating with a regimen server (such as server 313, e.g.) or with a consultant (such as expert 314) remotely. Alternatively or additionally, supplier 370 can be configured to communicate with expert 314 via linkage 327 or with (another) user 360 via linkage 361. Alternatively or additionally, user 360 can access a component C1 381 (and optionally one or more additional components C2 382) in an inventory manager 380 via interface 362.
  • In some embodiments, system 300 is a computer or similar device with inventory maintenance capabilities. In performing operation 140 (of FIG. 1) or some variants described below, logic 340 can register a dispensation from an inventory, for example by receiving an indication of the dispensation via user interface 338. Circuitry 330 can respond as appropriate by indicating a request quantity (at operation 150, e.g.), such as by transmitting the request quantity via link 321 as an order (to supplier 370, e.g.) or as a validation request (to a physician or other expert 314, e.g.).
  • Referring now to FIG. 4, there is shown another example system 400 able to perform operational flow 100 of FIG. 1 and many similar variations such as those of FIG. 5, 7, 8, 10, 12, or 13. System 400 comprises circuitry 440 for registering a nutraceutical-containing dispensation from an inventory and module 470 for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen. Circuitry 440 can adjoin, overlap, or otherwise be operable to interact with module 470.
  • Module 470 optionally comprises circuitry 471 for determining the request quantity partly based on a user preference. Alternatively or additionally, module 470 can comprise one or more of circuitry 472 for implementing the consumption regimen, medium 473 for storing at least the request quantity, circuitry 474 for confirming the nutraceutical-containing dispensation, or medium 475 bearing one or more instructions for generating the request quantity.
  • Also as shown, alternatively or additionally, system 400 can further comprise circuitry 481 for receiving at least a portion of the consumption regimen remotely. Alternatively or additionally, system 400 can further comprise circuitry 482 for identifying a compound comprising the request quantity, circuitry 483 for receiving a user preference, circuitry 484 for authenticating a user input, circuitry 485 for receiving an update of the consumption regimen, or circuitry 486 for receiving an update of the module for responding to the registering by indicating a request quantity.
  • Referring now to FIG. 5, there are shown various optional features of operational flow 100 of FIG. 1. Operation 140—registering a nutraceutical-containing dispensation from an inventory—may include one or more operations such as operation 543, which depicts confirming the nutraceutical-containing dispensation (e.g., dispensation confirmation logic 1443 confirming that a user 1460 has removed about 6 grams of St. John's wort from nutraceutical bin 1445 over the course of a week, such as, for example, dispensation confirmation logic 1443 comparing starting and ending volumes of St. John's wort in nutraceutical bin 1445). Operation 543 can likewise be performed by dispensation confirmation logic 1443 receiving a user input affirming the dispensation, for example, or by a module 470 that includes circuitry 474 of FIG. 4.
  • In various implementations, user system 1400 of FIG. 14 or system 400 of FIG. 4 can alternatively or additionally be configured to perform operation 150—responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen—by including one or more of operation 551, operation 552, operation 556, operation 557, operation 558, or operation 560. Operation 551 comprises receiving a user preference (e.g., user interface 1462 receiving a preference from user 1460 that user 1460 desires a high-energy formulation of his regimen), such as can be performed by a system 400 that includes circuitry 483 of FIG. 4.
  • Operation 552 comprises identifying a compound comprising the request quantity (e.g., compound identification logic 1496 identifying a nutraceutical such as bee pollen or ginkgo biloba). For example, if the electronic inventory 1456 indicates that the nutraceutical bin 1445 contains bee pollen and the user data 1454 indicates a preference for a high energy regimen, compound identification logic 1496 can identify bee pollen as a desirable nutraceutical by updating regimen description 1455. In other embodiments, operation 552 can be performed a variant of system 400 that includes circuitry 482.
  • Operation 556 comprises determining the request quantity partly based on a user preference (e.g., quantity determination logic 1490 determining that user 1460 has requested one pound of a protein supplement in response to a user preference for one-month-based purchases). The user data 1454 can also include one or more preferences relating to nutraceutical price, freshness and/or diversity, or the like. In other embodiments, operation 556 can be performed by a module 470 that includes circuitry 471 of FIG. 4.
  • Operation 557 comprises receiving the request quantity (e.g., user interface 1462 can receive data indicating a suggested amount of 50 tablets of a vitamin B complex), which can then be displayed to user 1460 or stored for later use, for example. In other embodiments, the request quantity can likewise be received from module 470 after executing the one or more instructions for generating the request quantity borne by medium 475.
  • Operation 558 comprises storing the request quantity (e.g., user interface 1462 storing a message in user data 1454 containing several suggested reorder amounts until user 1460 logs in again). In other embodiments, operation 558 can be performed with medium 473 of FIG. 4 or with medium 350 of FIG. 3. These or other media of system 400 can likewise store data related to the request quantity, of course, such as other request quantities, medical history data, security information, supplier identification, user preferences, or instructions in light of teachings herein.
  • Operation 560—performing one or more additional operations—may include one or more of the following operations: 561, 562, 563, 564, and/or 566. Operation 561 depicts receiving an update of the consumption regimen remotely (e.g., network interface 1492 receiving an indication that a given expert's diet regimen now allows up to 280 grams of protein supplement per week). This information can then be used by scheduler 1483 or stored in regimen description 1455 for later display to user 1460, for example.
  • Operation 562 depicts scheduling the consumption regimen (e.g., scheduler 1483 using a received update in changing the current regimen to allow at most 40 grams of protein per day). In other embodiments, operation 562 can be performed by a module 470 that includes circuitry 472 of FIG. 4.
  • Operation 563 depicts receiving an update of a module (e.g., module update logic 1470 receiving version 2.7 of a data file relied upon by compound identification logic 1496, and using it to replace version 2.8 previously in effect). In other embodiments, operation 563 can be performed by a system 400 that includes circuitry 486 of FIG. 4.
  • Operation 564 depicts receiving at least a portion of the consumption regimen (e.g., network interface 1492 receiving a list of all 45 nutraceuticals that can be required by regimen X). User 1460 can use this information in determining whether regimen X will require any unusual purchases, for example. In other embodiments, operation 564 can be performed by circuitry 481 of FIG. 4 or by logic 240 of FIG. 2, in some embodiments.
  • Operation 566 depicts authenticating a user input (e.g., authentication logic 1466 confirming the correctness of a password input by user 1460). In other embodiments, operation 566 can be performed by a system 400 that includes circuitry 484 of FIG. 4.
  • Referring now to FIG. 6, there is shown another example system 600 able to perform many variants of flow 100 described with reference to one or more of FIG. 5, 7, 8, 10, 12, or 13. System 600 can be configured to perform these variants with or without proximity or direct interaction with any user or inventory manager, except those few variants for which context dictates otherwise.
  • System 600 includes circuitry 650 for registering a dispensation from an inventory within a module 630 for responding to the registering by indicating a request, consistent with flow 100 of FIG. 1. As shown, module 630 can also include one or more of computing device 634, logic 636, or logic 638. Circuitry 650 can optionally include one or more of logic 654, logic 656, or memory 658. Storage 660 can optionally include one or more of code 667, data 668 (which can comprise historical data or inventory data, e.g.), or other data 670 such as one or more regimens 672, 674.
  • In some embodiments, logic 654 can comprise logic for prompting the test result (and/or other information that may relate to the subject) by requesting a test that partly depends on a medical history of the subject, for example, by transmitting a prompting signal as output 622 to network 620. (See FIGS. 11&12.) Alternatively or additionally, system 600 can perform a flow 100 including an operation 556, for example, based on a user preference received via input 621 and archived in storage 660.
  • Referring now to FIG. 7, there are shown various optional features of operational flow 100 of FIG. 1 or 5. In various implementations, system 600 of FIG. 6 can optionally be configured to perform flow 100 with one or more of operation 743 or operation 749.
  • Operation 743 comprises applying one or more inventory maintenance criteria to the inventory and to the nutraceutical-containing dispensation (e.g., inventory maintenance logic 1447 determining that a family's current regimen will exhaust the family's annis root in nutraceutical bin 1445 in less than a triggering time of two weeks). The criteria can likewise include a default or user-specified upper limit on a monetary value of an inventory, for example, or a maximum acceptable age of a perishable nutraceutical-containing compound. In some variants of the embodiment of FIG. 6, in response to receiving an input 621 indicating that a user's inventory manager is nearly full, for example, applying the criteria may accordingly reduce the request quantity to avoid spoilage, substantial investment in an ineffective or unneeded regimen, or other forms of waste. Also, system 600 optionally includes logic 638 comprising logic for querying a user responsive to the registering (at operation 749), such as by transmitting one or more requests as output 622 to network 620. This approach can help tailor the regimen by seeking input about a subject when a user is likely to be available, for example, around the time of the registering.
  • Operation 749 comprises querying a user responsive to the registering (e.g., user query logic 1446 sending a request to user 1460 to know whether a child still has a flu, to facilitate a decision of whether to reorder).
  • Operation 754 comprises retrieving at least a portion of the consumption regimen at least partly based on one or more attributes of a primary subject (e.g., storage logic 1450 selecting a portion of the contents of regimen description 1455 based on learning that the primary subject is a 6′2″ man who is slightly overweight). In some embodiments, operation 754 can include retrieving a regimen (regimen 672 of FIG. 6, e.g.) unique to the subject. Absent such an individualized regimen, even a few attributes such as age or symptom can form a basis for an effective regimen.
  • Operation 755 comprises selecting the request quantity partly based on an increment size of an inventory (e.g., quantity determination logic 1490 deciding to suggest a second 1-pound tin of herbal tea even when 4 single-ounce packets would have been a less costly way to reach a total of 20 ounces). In other embodiments, data 668 of FIG. 6 may identify the increment size, for example, used by computing device 634 for performing the selecting operation 755.
  • Operation 757 comprises receiving a user input indicating at least one of a nutraceutical or a symptom (e.g., compound identification logic 1496 receiving an indication of a symptom of “having foot cramps” from subject description 1453 or user 1460). The user input may be received via a questionnaire (electronic or paper, e.g.), for example.
  • Operation 758 comprises selecting a nutraceutical at least partly based on one or more symptoms (e.g., compound identification logic 1496 selecting calcium and magnesium citrate responsive to an indication of foot cramps).
  • Referring now to FIG. 8, there are shown various optional features of operational flow 100 of FIG. 1, 5, or 7. In various implementations, system 200 of FIG. 2 or user system 1400 of FIG. 14 can be configured to perform flow 100 with operation 140 including one or more of operation 841, operation 843, operation 847, operation 848, or operation 849.
  • Operation 841 comprises dispensing a nutraceutical (e.g., dispensation confirmation logic 1443 sending an instruction to nutraceutical bin 1445 or to user 1460 via display 1467). In other embodiments, inventory manager 280 likewise performs operation 841, for example, by dispensing a nutraceutical-containing component 282 responsive to an instruction (via linkage 232) from primary module 210. The registering can optionally cause or enable or result from the dispensing operation 841, or stand in some other relation to the dispensing operation 841, conditional or otherwise.
  • Operation 843 comprises combining a mineral with an amino acid (e.g., regimen implementation logic 1480 implementing a nutraceutical combination including an amino acid chelated calcium). In other embodiments, for a subject who takes a steady regimen including more than one component (such as these), compound identification logic 1496 can optionally streamline regimen implementation by preferring multivitamins and other products that encapsulate more than one regimen component in a single article (tablet, e.g.) or otherwise consolidate consumption.
  • Operation 847 comprises registering a received antioxidant-containing component apportioned into one or more capsules (e.g., inventory maintenance logic 1447 receiving an electronic inventory update to show that vitamin C capsules have been added to nutraceutical bin 1445). Operation 848 depicts allocating a multivitamin supplement component apportioned into one or more increments of a uniform increment size (e.g., inventory maintenance logic 1447 reserving all 100 identical tablets for the use of one person who draws from nutraceutical bin 1445). Operation 849 comprises forming the nutraceutical-containing dispensation as a combination containing one or more of the capsules and one or more of the increments (e.g., inventory maintenance logic 1447 generating a dispensation specifying two capsules and one tablet, which dispensation can then be included in a message displayed to user 1460).
  • FIG. 8 also shows various optional features of operational flow 100 of FIG. 1, 5, or 7 comprising additional operation 852, operation 854, or operation 856. In various implementations, system 300 of FIG. 3 or user system 1400 of FIG. 4 can be configured to perform flow 100 with operation 150 including one or more of these additional operations.
  • Operation 852 comprises receiving a validation of at least a portion of the consumption regimen (e.g., network interface 1492 receiving a message of approval from the subject's doctor concerning a detoxifying regimen that includes calcium D-glucarate). In some embodiments relating to FIG. 3, the validation of operation 852 can be received from user 360 or expert 314, for example, optionally in response to an automated request for such a validation. The request can define or justify the portion of the consumption regimen briefly, for example, and specify an action (such as clicking a button or entering a code, e.g.) by which the validation can be generated. The responding operation 150 can optionally be made conditional on receiving the validation before a deadline, for example, or can otherwise affect a condition or manner by which system 300 will complete the responding operation 150.
  • Operation 854 comprises receiving at least a portion of a health regimen that includes the consumption regimen (e.g., regimen description 1455 receiving a complete diet and exercise regimen). In some variants of FIG. 3, for example, the portion can be received by circuitry 330 via network 320. System 300 can present several such health regimens of interest to user 360 via interface 338, for example, prompting user 360 to adopt one or more of the health regimens. Logic 340 can then implement one or more user-adopted regimens by storing one or more instructions of each of the adopted regimens in medium 350 (a memory, e.g.). Likewise, as will be shown following, system 300 can perform operation 856 before, during, after, or without the above-described adoption operation. See FIG. 10, for example.
  • Operation 856 comprises receiving one or more components of the consumption regimen (e.g., regimen description 1455 receiving a complete diet and exercise regimen). Other components of the consumption regimen can optionally be obtained, for example, by deriving them from regimen description 1455.
  • Referring now to FIG. 9, there are shown further optional features of system 400 of FIG. 4. As explained above, system 400 comprises circuitry 440 for registering a nutraceutical-containing dispensation from an inventory and module 470 for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
  • Module 470 optionally comprises display 971 configured for digitally indicating the request quantity. Alternatively or additionally, module 470 can comprise one or more of display 972 configured for graphically indicating the request quantity, module 973 for receiving input from a user locally, or module 974 for predicting a state of the inventory. Alternatively or additionally, module 470 can comprise signal-bearing medium 980 bearing one or more instructions such as those of FIG. 11 below.
  • Also as shown, alternatively or additionally, system 400 can further comprise circuitry 981 for accessing a network. Alternatively or additionally, system 400 can further comprise circuitry 982 for determining whether any update can be obtained for the consumption regimen, circuitry 983 for obtaining a regimen remotely, circuitry 984 for communicating with a consultant remotely, circuitry 985 for communicating with a supplier, or circuitry 986 for communicating with an inventory manager containing the inventory.
  • Referring now to FIG. 10, there are shown various optional features of operational flow 100 of FIG. 1, 5, 7 or 8. In various implementations, user system 1400 of FIG. 14 or system 400 of FIG. 9 can optionally be configured to perform flow 100 with operation 140 including one or more of operation 1041, operation 1046, operation 1047, operation 1048, or operation 1049. Operation 1041 comprises accessing a network (e.g., user query logic 1446 contacting a consultant or other user via the Internet). In other embodiments, operation 1041 is performed by circuitry 981 in the system 400 as shown in FIGS. 4 & 9.
  • Operation 1046 comprises receiving input from a user locally (e.g., user query logic 1446 receiving a query response from user 1460 through user interface 1462).
  • Operation 1047 comprises predicting a state of the inventory (e.g., event predictor 1448 predicting that a supply of zinc in nutraceutical bin 1445 will run out in 28 days in lieu of restocking or a regimen change). In some embodiments, operation 1047 can be performed by a variant of system 400 comprising module 974. The prediction may be based on one or more attributes of one or more dispensations such as the registered one(s), for example, or upon the consumption regimen or a current state of the inventory. The predicted state may be detailed, such as a complete description of each component and its ingredients, its age, its location, and the like. The predicted state may alternatively be more basic, such as “adequate” or “in need of component Z.” The predicted state may also be expressed in various forms, such as a duration or a percentage.
  • Operation 1048 comprises postponing an action responsive to determining that the predicted state meets one or more criteria (e.g., scheduler 1483 postponing ordering any single item over $200 without a specific approval from user 1460).
  • Operation 1049 comprises communicating with an inventory manager containing the inventory (e.g., dispensation confirmation logic 1443 or inventory maintenance logic 1447 communicating with inventory manager 1444 containing an inventory of supplements and medications in nutraceutical bin 1445).
  • Operation 1052 comprises determining whether any alternative, substitute, or other update can be obtained for the consumption regimen (e.g., module update logic 1470 reviewing an accumulation of content periodically within or through network interface 1492 to determine whether the Bone-Up™ regimen has published any updates since last month). The determining can be performed by checking a mailbox, for example, or otherwise by sending a message into a network such as may be received by a server. Making a negative determination can be performed by receiving a negative reply or by waiting a given duration without receiving a reply, for example, or by making some similarly reasonable inference derived from one or more received signals.
  • Operation 1053 comprises receiving an available regimen remotely (e.g., network interface 1492 receiving a mark-up language segment relating to at least one nutraceutical from a clinic in another state). Operation 1054 comprises adopting the available regimen as the consumption regimen (e.g., module update logic 1470 responding to a user selection by changing to a simpler regimen).
  • In some embodiments, system 400 comprises circuitry 983 that can perform operation 1053 by receiving an available regimen in response to a request or subscription, for example, or may select the available regimen as a preferable regimen automatically using information about the subject.
  • Operation 1055 comprises graphically indicating the request quantity (e.g., display 1467 showing a pixel image of two bottles that can obviate a translation or enable a person to understand and approve a purchase without having to read). In some embodiments, display 972 performs operation 1055 by showing a first component that is visually distinguishable from at least a second component, such as by color or shape.
  • Operation 1056 comprises digitally indicating the request quantity (e.g., display 1467 showing a default reorder list to a nutraceutical vendor). Alternatively or additionally, indicating operation 1056 can be performed by transmitting the request quantity digitally via a conduit (of FIG. 11, e.g.) or a wireless link (of FIG. 3, e.g.).
  • Referring now to FIG. 11, a system 1100 includes a signal-bearing medium 1180 that can comprise (or interact with) a conduit 1120, a disk 1130, an integrated circuit 1140, or a computing device 1150. System 1100 can further include a dispenser 1170. Medium 1180 can optionally bear one or more instructions 1160 comprising at least one of (a) one or more instructions for registering a nutraceutical-containing dispensation from an inventory and (b) one or more instructions for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
  • Alternatively or additionally, medium 1180 can bear one or more instructions 1162 for recording the nutraceutical-containing dispensation with other medical history data of a subject. The other medical history data can include one or more prior recordings of a dispensation, for example. Alternatively or additionally, medium 1180 can bear one or more instructions 1163 for performing the nutraceutical-containing dispensation. Alternatively or additionally, medium 1180 can bear one or more instructions 1164 for prompting the nutraceutical-containing dispensation. Alternatively or additionally, medium 1180 can bear one or more instructions 1165 for detecting the nutraceutical-containing dispensation. Alternatively or additionally, medium 1180 can bear one or more instructions 1166 for determining the request quantity. Alternatively or additionally, medium 1180 can bear one or more instructions 1168 comprising at least one of (a) one or more instructions for receiving an indication of a quantity within each of one or more delivery units and (b) one or more instructions for indicating the request quantity as a number of the one or more delivery units. A given set of one or more instructions can comprise more than one of instructions 1162-1168, of course, optionally executable by computing device 1150.
  • Referring now to FIG. 12, there are shown various optional features of operational flow 100 of FIG. 1, 5, 7, 8, or 10. In various implementations, system 1100 of FIG. 11 can optionally be configured to perform flow 100 with operation 140 including one or more of operation 1242, operation 1243, operation 1246, operation 1247, or 1249.
  • Operation 1242 comprises performing the nutraceutical-containing dispensation (e.g., regimen implementation logic 1480 generating a dispensation identifying a list of pharmaceuticals and nutraceuticals). In some embodiments, system 1100 performs operation 1242 by transmitting instructions 1163 via medium 1180 to dispensers 170.
  • Operation 1243 comprises prompting the nutraceutical-containing dispensation (e.g., regimen implementation logic 1480 causing inventor manager 1444 to perform a physical dispensation immediately). This can likewise be performed by a computing device 1150, for example, such as by transmitting a dispensing command or by otherwise causing an actuation of a dispenser.
  • Operation 1246 comprises detecting the nutraceutical-containing dispensation (e.g., dispensation confirmation logic 1443 detecting a physical dispensation from inventory manager 1444 or a planned dispensation from regimen implementation logic 1480). In another example, operation 1246 can be performed by integrated circuit 1140 before, during, after, or without the physical dispensation. The dispensation to be registered can optionally be conditional, scheduled, or actual.
  • Operation 1247 comprises responding to a result of a test indicating a state of a subject (e.g., user query logic 1446 receiving a “yes” response after asking the user 1460 whether the subject has a fever). In some embodiments of system 1100 of FIG. 11, for example, operation 1247 can be performed by executing one or more instructions 1166 for determining the request quantity.
  • Operation 1249 comprises recording the nutraceutical-containing dispensation with other medical history data of a subject (e.g., user query logic 1446 recording the dispensation in subject description 1453). In some embodiments, operation 1249 is performed by computing device 1150 performing instruction(s) 1162.
  • Operation 1251 comprises displaying a performance indicator of the regimen relating to a potential result of following the regimen (e.g., display 1467 can show a comparison between a likelihood of catching a flu with a probiotic-containing yogurt regimen and a similar likelihood without a regimen). The potential result can be tangible, intangible, subjective, objective, or some combination of these. The performance ratio or other indicator can comprise an estimated probability of a measurable improvement, a ratio of “satisfied” regimen subscribers to “dissatisfied” regimen subscribers, a record of subjective experience, an anecdotal log, a rating, a research summary, a certification, an endorsement, or some other indicator.
  • Operation 1253 comprises receiving an indication of a quantity within each of one or more delivery units (e.g., electronic inventory 1456 including an indication of a per-unit “dose”). The quantity can be a nominal increment of mass (such as milligrams of a vitamin, e.g.), a count (of eggs, e.g.), a length, or some other convenient increment. In some embodiments, a code module comprising one or more instructions 1166 performs operation 1253 before or during operation 1254.
  • Operation 1254 comprises indicating the request quantity as a number of the one or more delivery units (e.g., regimen description 1455 describing a regimen as 2 units of item X, et cetera, with item X defined only in electronic inventory 1456).
  • Operation 1255 comprises detecting a condition (e.g., quantity determination logic 1490 detecting a user login or other action via user interface 1462). The condition can comprise a substantially periodic event, for example, such as an appointment, a day of the month, a time of day, a mealtime, a work break, or the like. The condition can also comprise a storm or other weather condition, a job change or price change or other economic event, a smoking habit or some other personal condition, or any other condition that may affect the subject's life.
  • The detecting can be triggered by a signal from a calendar program, an alarm clock, a sensor, a network event, or a real time trigger, for example. In some variants of embodiments described above, system 300 of FIG. 3 performs operation 150 responsive to one or more criteria that depend on the detected event(s) as well as the request quantity and the regimen. A care provider can use system 300 to adjust or otherwise update a regimen-implementing request automatically, responsive to a scheduled visit by a patient, for example, if system 300 performs operation 1256.
  • Operation 1256 comprises responding to the condition by determining the request quantity (e.g., quantity determination logic 1490 responding to a user action by refreshing a proposed order by using a current system time).
  • Operation 1258 comprises determining the request quantity partly based on an indication of a visible attribute or a behavior of a subject (e.g., compound identification logic 1496 and quantity determination logic 1490 identifying and ordering a quantity of non-prescription lithium responsive to chronic extreme mood swings). The subject, a psychologist, a psychiatrist, a parent, or some other observer may provide an objective indication (conscious, e.g.), for example, or a subjective indication (irritable or fatigued, e.g.) of the attribute or behavior. The request quantity may be zero if the visible attribute or the behavior indicates a negative reaction by the subject to a component of that regimen, for example. The indication may relate to a facial attribute (“bags under the eyes,” e.g.), some other skin condition (“rash,” e.g.), or any other visible attribute of a subject.
  • Operation 1259 comprises indicating the request quantity via a display of a hand-held device (e.g., display 1467 indicating the quantity via a cell phone, a camera, or a hybrid device). In various embodiments, any of the above-described systems can optionally include a display, for example. Alternatively or additionally, the system can comprise a hand-held device such as a cell phone, wrist watch or the like.
  • Referring now to FIG. 13, there are shown various optional features of operational flow 100 of FIG. 1, 5, 7, 8, 10, or 12. Operation 140—registering a nutraceutical-containing dispensation from an inventory—may include one or more of the following operations: 1341, 1342, 1343, 1344, or 1345. Operation 1341 depicts listing one or more nutraceuticals and one or more pharmaceuticals in the nutraceutical-containing dispensation (e.g., regimen implementation logic 1480 including these items in a displayed or transmitted dispensation). Operation 1342 depicts listing a vitamin and/or a mineral in the nutraceutical-containing dispensation (e.g., regimen implementation logic 1480 including these items in a displayed or transmitted dispensation). Operation 1343 depicts listing a protein, an amino acid, an oil, and/or a fat in the nutraceutical-containing dispensation (e.g., regimen implementation logic 1480 including these items in a displayed or transmitted dispensation). Operation 1344 depicts listing a traditional remedy in the nutraceutical-containing dispensation (e.g., regimen implementation logic 1480 including these items in a displayed or transmitted dispensation). Operation 1345 depicts receiving a user report of the nutraceutical-containing dispensation (e.g., user query logic 1446 requesting and receiving a notification from user 1460 that the dispensation is planned).
  • Operation 1360—performing one or more additional operations—may include one or more of the following operations: 1361, 1362, 1363, 1364, 1366, 1368, or
  • 1369. Operation 1361 depicts receiving a request for a subscription (e.g., user interface 1462 receiving a decision that user 1460 is subscribing to the Adkins diet). Operation 1362 depicts obtaining data from one or more remote sources (e.g., registration logic receiving the registration(s) as the obtained data from a nutraceutical bin 1445 that can be remote). Operation 1363 depicts obtaining data via a network (e.g., network interface 1492 receiving data via the Internet).
  • Operation 1364 depicts receiving at least one of a diagnosis or one or more observations (e.g., subject description 1453 receiving an indication that a particular subject has rheumatoid arthritis). Operation 1366 depicts receiving at least one of a prognosis or another prediction (e.g., subject description 1453 receiving an indication that a 2-week convalescence is expected). The diagnosis or prognosis can optionally be based on one or more test results and/or reports by others, observations, predictions, reports, history, or other indications of status. The diagnosis or prognosis may relate to a subject who has adopted the consumption regimen, for example, and may warrant storing the diagnosis in a medical history. The subject may be diagnosed as having an allergy to seafood, for example, which may bear against a fish oil supplement. Substantially the same criterion (“no fish,” e.g.) may effectively become a part of a given subject's regimen in other circumstances as well. It may arise from a received user instruction or preference (“no fish,” e.g.), a user status (“vegan,” e.g.), or otherwise arise from a received input (via interface 1462, e.g.). The subject may be diagnosed with osteoporosis, as another example, which may bear toward a calcium-containing (or higher-calcium) regimen.
  • Operation 1368 comprises communicating with a consultant remotely (e.g., network interface 1492 automatically notifying a subject's dietician at a remote facility). Operation 1369 comprises communicating with a supplier (e.g., network interface 1492 requesting the supplier's availability and lead times for products of interest). These operations can generate timely information about the availability or advisability of an available regimen, for example, facilitating appropriate adjustments at operation 150. Many embodiments described herein allow for a more sophisticated and cost-effective approach to building and maintaining an inventory of effective remedies.
  • Those having skill in the art will recognize that the state of the art has progressed to the point where there is little distinction left between hardware and software implementations of aspects of systems; the use of hardware or software is generally (but not always, in that in certain contexts the choice between hardware and software can become significant) a design choice representing cost vs. efficiency tradeoffs. Those having skill in the art will appreciate that there are various vehicles by which processes and/or systems and/or other technologies described herein can be effected (e.g., hardware, software, and/or firmware), and that the preferred vehicle will vary with the context in which the processes and/or systems and/or other technologies are deployed. For example, if an implementer determines that speed and accuracy are paramount, the implementer may opt for a mainly hardware and/or firmware vehicle; alternatively, if flexibility is paramount, the implementer may opt for a mainly software implementation; or, yet again alternatively, the implementer may opt for some combination of hardware, software, and/or firmware. Hence, there are several possible vehicles by which the processes and/or devices and/or other technologies described herein may be effected, none of which is inherently superior to the other in that any vehicle to be utilized is a choice dependent upon the context in which the vehicle will be deployed and the specific concerns (e.g., speed, flexibility, or predictability) of the implementer, any of which may vary. Those skilled in the art will recognize that optical aspects of implementations will typically employ optically-oriented hardware, software, and or firmware.
  • The foregoing detailed description has set forth various embodiments of the devices and/or processes via the use of block diagrams, flowcharts, and/or examples. Insofar as such block diagrams, flowcharts, and/or examples contain one or more functions and/or operations, it will be understood by those within the art that each function and/or operation within such block diagrams, flowcharts, or examples can be implemented, individually and/or collectively, by a wide range of hardware, software, firmware, or virtually any combination thereof. In one embodiment, several portions of the subject matter described herein may be implemented via Application Specific Integrated Circuits (ASICs), Field Programmable Gate Arrays (FPGAs), digital signal processors (DSPs), or other integrated formats. However, those skilled in the art will recognize that some aspects of the embodiments disclosed herein, in whole or in part, can be equivalently implemented in integrated circuits, as one or more computer programs running on one or more computers (e.g., as one or more programs running on one or more computer systems), as one or more programs running on one or more processors (e.g., as one or more programs running on one or more microprocessors), as firmware, or as virtually any combination thereof, and that designing the circuitry and/or writing the code for the software and or firmware would be well within the skill of one of skill in the art in light of this disclosure. In addition, those skilled in the art will appreciate that the mechanisms of the subject matter described herein are capable of being distributed as a program product in a variety of forms, and that an illustrative embodiment of the subject matter described herein applies regardless of the particular type of signal bearing medium used to actually carry out the distribution. Examples of a signal bearing medium include, but are not limited to, the following: a recordable type medium such as a floppy disk, a hard disk drive, a Compact Disc (CD), a Digital Video Disk (DVD), a digital tape, a computer memory, etc.; and a transmission type medium such as a digital and/or an analog communication medium (e.g., a fiber optic cable, a waveguide, a wired communications link, a wireless communication link, etc.).
  • While particular aspects of the present subject matter described herein have been shown and described, it will be apparent to those skilled in the art that, based upon the teachings herein, changes and modifications may be made without departing from this subject matter described herein and its broader aspects and, therefore, the appended claims are to encompass within their scope all such changes and modifications as are within the true spirit and scope of this subject matter described herein. Furthermore, it is to be understood that the invention is solely defined by the appended claims. It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to inventions containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should typically be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations. In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should typically be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, typically means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, and C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). In those instances where a convention analogous to “at least one of A, B, or C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, or C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). It will be further understood by those within the art that any disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms. For example, the phrase “A or B” will be understood to include the possibilities of “A” or “B” or “A and B.” Moreover, “can” and “optionally” and other permissive terms are used herein for describing optional features of various embodiments. These terms likewise describe selectable or configurable features generally, unless the context dictates otherwise.
  • The herein described aspects depict different components contained within, or connected with, different other components. It is to be understood that such depicted architectures are merely exemplary, and that in fact many other architectures can be implemented which achieve the same functionality. In a conceptual sense, any arrangement of components to achieve the same functionality is effectively “associated” such that the desired functionality is achieved. Hence, any two components herein combined to achieve a particular functionality can be seen as “associated with” each other such that the desired functionality is achieved, irrespective of architectures or intermedial components. Likewise, any two components so associated can also be viewed as being “operably connected,” or “operably coupled,” to each other to achieve the desired functionality. Any two components capable of being so associated can also be viewed as being “operably couplable” to each other to achieve the desired functionality. Specific examples of operably couplable include but are not limited to physically mateable and/or physically interacting components and/or wirelessly interactable and/or wirelessly interacting components and/or logically interactable and/or logically interacting components.
  • While certain features of the described implementations have been illustrated as disclosed herein, many modifications, substitutions, changes and equivalents will now occur to those skilled in the art. It is, therefore, to be understood that the appended claims are intended to cover all such modifications and changes as fall within the true spirit of the embodiments of the invention.

Claims (166)

1. A method comprising:
registering a nutraceutical-containing dispensation from an inventory; and
responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
2. (canceled)
3. (canceled)
4. (canceled)
5. The method of claim 1, wherein responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
receiving a user preference; and
identifying a compound comprising the request quantity.
6. (canceled)
7. (canceled)
8. (canceled)
9. The method of claim 1, wherein responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
receiving the request quantity; and
storing the request quantity.
10. (canceled)
11. (canceled)
12. (canceled)
13. (canceled)
14. (canceled)
15. The method of claim 1, further comprising:
receiving at least a portion of the consumption regimen.
16. (canceled)
17. The method of claim 1, further comprising:
receiving a request for a subscription.
18. (canceled)
19. (canceled)
20. (canceled)
21. (canceled)
22. The method of claim 1, wherein responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
retrieving at least a portion of the consumption regimen at least partly based on one or more attributes of a primary subject.
23. (canceled)
24. The method of claim 1, wherein responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
receiving a user input indicating at least one of a nutraceutical or a symptom.
25. (canceled)
26. (canceled)
27. (canceled)
28. (canceled)
29. The method of claim 1, wherein registering a nutraceutical-containing dispensation from an inventory comprises:
allocating a multivitamin supplement component apportioned into one or more increments of a uniform increment size.
30. (canceled)
31. (canceled)
32. (canceled)
33. (canceled)
34. (canceled)
35. (canceled)
36. (canceled)
37. (canceled)
38. (canceled)
39. (canceled)
40. (canceled)
41. The method of claim 1, wherein responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
receiving an available regimen remotely; and
adopting the available regimen as the consumption regimen.
42. (canceled)
43. (canceled)
44. The method of claim 1, wherein registering a nutraceutical-containing dispensation from an inventory comprises:
predicting a state of the inventory.
45. (canceled)
46. (canceled)
47. (canceled)
48. (canceled)
49. (canceled)
50. (canceled)
51. The method of claim 1, wherein responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
displaying a performance indicator of the regimen relating to a potential result of following the regimen.
52. (canceled)
53. The method of claim 1, wherein responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
receiving an indication of a quantity within each of one or more delivery units; and
indicating the request quantity as a number of the one or more delivery units.
54. (canceled)
55. The method of claim 1, wherein responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
detecting a condition; and
responding to the condition by determining the request quantity.
56. The method of claim 1, wherein responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
determining the request quantity partly based on an indication of a visible attribute or a behavior of a subject.
57. (canceled)
58. (canceled)
59. (canceled)
60. (canceled)
61. (canceled)
62. (canceled)
63. (canceled)
64. (canceled)
65. A system comprising:
means for registering a nutraceutical-containing dispensation from an inventory; and
means for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
66. (canceled)
67. (canceled)
68. (canceled)
69. (canceled)
70. (canceled)
71. The system of claim 65, wherein the means for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
means for storing the request quantity.
72. (canceled)
73. (canceled)
74. (canceled)
75. (canceled)
76. (canceled)
77. (canceled)
78. The system of claim 65, wherein the means for registering a nutraceutical-containing dispensation from an inventory comprises:
means for applying one or more inventory maintenance criteria to the inventory and to the nutraceutical-containing dispensation.
79. (canceled)
80. The system of claim 65, further comprising:
means for receiving at least one of a prognosis or another prediction.
81. The system of claim 65, wherein the means for registering a nutraceutical-containing dispensation from an inventory comprises:
means for querying a user responsive to the registering.
82. The system of claim 65, wherein the means for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
means for retrieving at least a portion of the consumption regimen at least partly based on one or more attributes of a primary subject.
83. (canceled)
84. (canceled)
85. The system of claim 65, wherein the means for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
means for selecting a nutraceutical at least partly based on one or more symptoms.
86. (canceled)
87. (canceled)
88. (canceled)
89. (canceled)
90. (canceled)
91. (canceled)
92. The system of claim 65, wherein the means for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
means for receiving at least a portion of a health regimen that includes the consumption regimen.
93. (canceled)
94. (canceled)
95. (canceled)
96. (canceled)
97. (canceled)
98. (canceled)
99. (canceled)
100. (canceled)
101. The system of claim 65, wherein the means for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
means for adopting the available regimen as the consumption regimen.
102. The system of claim 65, wherein the means for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
means for graphically indicating the request quantity.
103. (canceled)
104. (canceled)
105. (canceled)
106. The system of claim 65, wherein the means for registering a nutraceutical-containing dispensation from an inventory comprises:
means for performing the nutraceutical-containing dispensation.
107. The system of claim 65, wherein the means for registering a nutraceutical-containing dispensation from an inventory comprises:
means for prompting the nutraceutical-containing dispensation.
108. (canceled)
109. The system of claim 65, wherein the means for registering a nutraceutical-containing dispensation from an inventory comprises:
means for responding to a result of a test indicating a state of a subject
110. (canceled)
111. (canceled)
112. (canceled)
113. (canceled)
114. (canceled)
115. The system of claim 65, wherein the means for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
means for determining the request quantity partly based on an indication of a visible attribute or a behavior of a subject.
116. (canceled)
117. (canceled)
118. (canceled)
119. The system of claim 65, wherein the means for registering a nutraceutical-containing dispensation from an inventory comprises:
means for receiving a user report of the nutraceutical-containing dispensation.
120. A system comprising:
circuitry for registering a nutraceutical-containing dispensation from an inventory; and
a module for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
121. The system of claim 120, wherein the module for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
circuitry for determining the request quantity partly based on a user preference.
122. (canceled)
123. (canceled)
124. The system of claim 120, wherein the module for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen comprises:
circuitry for confirming the nutraceutical-containing dispensation.
125. (canceled)
126. (canceled)
127. The system of claim 120, further comprising:
circuitry for identifying a compound comprising the request quantity.
128. (canceled)
129. The system of claim 120, further comprising:
circuitry for authenticating a user input.
130. (canceled)
131. The system of claim 120, further comprising:
circuitry for receiving an update of the module for responding to the registering by indicating a request quantity.
132. (canceled)
133. (canceled)
134. (canceled)
135. (canceled)
136. (canceled)
137. (canceled)
138. The system of claim 120, further comprising:
circuitry for determining whether any update can be obtained for the consumption regimen.
139. The system of claim 120, further comprising:
circuitry for obtaining a regimen remotely.
140. The system of claim 120, further comprising:
circuitry for communicating with a consultant remotely.
141. (canceled)
142. The system of claim 120, further comprising:
circuitry for communicating with an inventory manager containing the inventory.
143. (canceled)
144. (canceled)
145. (canceled)
146. A system comprising:
a computing device; and
at least one of one or more instructions for registering a nutraceutical-containing dispensation from an inventory; and one or more instructions for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
147. (canceled)
148. (canceled)
149. (canceled)
150. (canceled)
151. The system of claim 146, further comprising:
one or more instructions for recording the nutraceutical-containing dispensation with other medical history data of a subject.
152. (canceled)
153. (canceled)
154. (canceled)
155. (canceled)
156. The system of claim 146, further comprising:
at least one of
one or more instructions for receiving an indication of a quantity within each of one or more delivery units; and
one or more instructions for indicating the request quantity as a number of the one or more delivery units.
157. A computer program product comprising:
a signal-bearing medium bearing at least one of
one or more instructions for registering a nutraceutical-containing dispensation from an inventory; and
one or more instructions for responding to the registering by indicating a request quantity partly based on the inventory and partly based on a consumption regimen.
158. (canceled)
159. (canceled)
160. (canceled)
161. (canceled)
162. (canceled)
163. (canceled)
164. (canceled)
165. (canceled)
166. (canceled)
US11/314,945 2005-11-17 2005-12-20 Generating a request from a nutraceutical inventory Abandoned US20070112591A1 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
US11/314,945 US20070112591A1 (en) 2005-11-17 2005-12-20 Generating a request from a nutraceutical inventory
US11/478,296 US20070124218A1 (en) 2005-11-30 2006-06-28 Computational and/or control systems related to individualized nutraceutical selection and packaging
US11/478,341 US20070124219A1 (en) 2005-11-30 2006-06-28 Computational and/or control systems related to individualized nutraceutical selection and packaging
US11/486,973 US20070174128A1 (en) 2005-11-30 2006-07-14 Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US11/486,998 US20070136092A1 (en) 2005-11-30 2006-07-14 Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US11/515,357 US8340944B2 (en) 2005-11-30 2006-09-01 Computational and/or control systems and methods related to nutraceutical agent selection and dosing
PCT/US2006/044658 WO2007061835A2 (en) 2005-11-17 2006-11-15 Generating a request from a nutraceutical inventory
PCT/US2006/047436 WO2007078746A2 (en) 2005-12-20 2006-12-12 Computational and/or control systems related to individualized nutraceutical selection and packaging
EP06845313A EP1964039A2 (en) 2005-12-20 2006-12-12 Computational and/or control systems and methods related to nutraceutical agent selection and dosing
PCT/US2006/047451 WO2008002322A2 (en) 2005-12-20 2006-12-12 Computational and/or control systems and methods related to nutraceutical agent selection and dosing
EP06845489A EP1964040A2 (en) 2005-12-20 2006-12-13 Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
PCT/US2006/047835 WO2007075378A2 (en) 2005-12-20 2006-12-13 Control systems for individualized pharmaceutical and nutraceutical selection and packaging
US11/824,529 US10296720B2 (en) 2005-11-30 2007-06-28 Computational systems and methods related to nutraceuticals
US11/824,604 US20080004909A1 (en) 2005-11-30 2007-06-28 Computational systems related to nutraceuticals
US11/888,613 US7827042B2 (en) 2005-11-30 2007-07-31 Methods and systems related to transmission of nutraceutical associated information
US11/893,606 US20080082272A1 (en) 2005-11-30 2007-08-15 Computational systems and methods related to nutraceuticals
US11/893,605 US20080052114A1 (en) 2005-11-30 2007-08-15 Computational systems and methods related to nutraceuticals
US11/893,608 US7974856B2 (en) 2005-11-30 2007-08-15 Computational systems and methods related to nutraceuticals
US11/900,637 US20080103746A1 (en) 2005-11-30 2007-09-11 Systems and methods for pathogen detection and response
US11/900,649 US20080210748A1 (en) 2005-11-30 2007-09-11 Systems and methods for receiving pathogen related information and responding
US11/900,660 US8068991B2 (en) 2005-11-30 2007-09-11 Systems and methods for transmitting pathogen related information and responding
US11/977,174 US8000981B2 (en) 2005-11-30 2007-10-22 Methods and systems related to receiving nutraceutical associated information
US12/011,008 US20080193919A1 (en) 2005-11-30 2008-01-22 Systems and methods for receiving pathogen related information and responding
US12/924,700 US20110145009A1 (en) 2005-11-30 2010-09-30 Methods and systems related to transmission of nutraceutical associatd information

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/283,548 US10042980B2 (en) 2005-11-17 2005-11-17 Providing assistance related to health
US11/291,532 US8532938B2 (en) 2005-11-17 2005-11-30 Testing-dependent administration of a nutraceutical
US11/291,482 US20070119928A1 (en) 2005-11-17 2005-11-30 Generating a nutraceutical request from an inventory
US11/314,945 US20070112591A1 (en) 2005-11-17 2005-12-20 Generating a request from a nutraceutical inventory

Related Parent Applications (3)

Application Number Title Priority Date Filing Date
US11/283,548 Continuation-In-Part US10042980B2 (en) 2005-11-17 2005-11-17 Providing assistance related to health
US11/291,482 Continuation-In-Part US20070119928A1 (en) 2005-11-17 2005-11-30 Generating a nutraceutical request from an inventory
US11/291,532 Continuation-In-Part US8532938B2 (en) 2005-11-17 2005-11-30 Testing-dependent administration of a nutraceutical

Related Child Applications (13)

Application Number Title Priority Date Filing Date
US11/453,571 Continuation-In-Part US20070289258A1 (en) 2005-11-30 2006-06-14 Individualized pharmaceutical selection and packaging
US11/474,109 Continuation-In-Part US20070299693A1 (en) 2005-11-30 2006-06-23 Customized visual marking for medication labeling
US11/478,296 Continuation-In-Part US20070124218A1 (en) 2005-11-30 2006-06-28 Computational and/or control systems related to individualized nutraceutical selection and packaging
US11/478,341 Continuation-In-Part US20070124219A1 (en) 2005-11-30 2006-06-28 Computational and/or control systems related to individualized nutraceutical selection and packaging
US11/486,973 Continuation-In-Part US20070174128A1 (en) 2005-11-30 2006-07-14 Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US11/515,357 Continuation-In-Part US8340944B2 (en) 2005-11-30 2006-09-01 Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US11/637,616 Continuation-In-Part US20080004905A1 (en) 2005-11-30 2006-12-11 Methods and systems for analysis of nutraceutical associated components
US11/824,604 Continuation-In-Part US20080004909A1 (en) 2005-11-30 2007-06-28 Computational systems related to nutraceuticals
US11/824,529 Continuation-In-Part US10296720B2 (en) 2005-11-30 2007-06-28 Computational systems and methods related to nutraceuticals
US11/893,606 Continuation-In-Part US20080082272A1 (en) 2005-11-30 2007-08-15 Computational systems and methods related to nutraceuticals
US11/893,608 Continuation-In-Part US7974856B2 (en) 2005-11-30 2007-08-15 Computational systems and methods related to nutraceuticals
US11/893,605 Continuation-In-Part US20080052114A1 (en) 2005-11-30 2007-08-15 Computational systems and methods related to nutraceuticals
US11/900,637 Continuation-In-Part US20080103746A1 (en) 2005-11-30 2007-09-11 Systems and methods for pathogen detection and response

Publications (1)

Publication Number Publication Date
US20070112591A1 true US20070112591A1 (en) 2007-05-17

Family

ID=38042004

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/283,548 Expired - Fee Related US10042980B2 (en) 2005-11-17 2005-11-17 Providing assistance related to health
US11/285,500 Abandoned US20070112588A1 (en) 2005-11-17 2005-11-22 User interface for providing assistance related to health
US11/314,945 Abandoned US20070112591A1 (en) 2005-11-17 2005-12-20 Generating a request from a nutraceutical inventory

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US11/283,548 Expired - Fee Related US10042980B2 (en) 2005-11-17 2005-11-17 Providing assistance related to health
US11/285,500 Abandoned US20070112588A1 (en) 2005-11-17 2005-11-22 User interface for providing assistance related to health

Country Status (2)

Country Link
US (3) US10042980B2 (en)
WO (1) WO2007061705A2 (en)

Citations (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446138A (en) * 1982-02-10 1984-05-01 Pack Howard M Method and composition for reducing weight
US4567185A (en) * 1983-05-13 1986-01-28 Key Pharmaceuticals, Inc. Endorphin blockage
US4838275A (en) * 1985-11-29 1989-06-13 Lee Arnold St J Home medical surveillance system
US4847764A (en) * 1987-05-21 1989-07-11 Meditrol, Inc. System for dispensing drugs in health care institutions
US5176285A (en) * 1991-08-26 1993-01-05 Shaw Thomas J Pill dispensing apparatus
US5279294A (en) * 1985-04-08 1994-01-18 Cascade Medical, Inc. Medical diagnostic system
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
US5495961A (en) * 1992-03-30 1996-03-05 Maestre; Federico A. Portable programmable medication alarm device and method and apparatus for programming and using the same
US5710578A (en) * 1987-12-09 1998-01-20 International Business Machines Corporation Computer program product for utilizing fast polygon fill routines in a graphics display system
US5737539A (en) * 1994-10-28 1998-04-07 Advanced Health Med-E-Systems Corp. Prescription creation system
US5758096A (en) * 1995-08-09 1998-05-26 Barsky; Howard System and method for personalized medication treatment management
US5873369A (en) * 1997-03-31 1999-02-23 Chronoslim P.C.E. Ltd. System for monitoring health conditions of an individual and a method thereof
US5882931A (en) * 1997-07-14 1999-03-16 Petersen; Roger Method and apparatus for performing urinalysis in real time
US5907291A (en) * 1997-06-05 1999-05-25 Vsm Technology Inc. Multi-patient monitoring apparatus and method
US6021202A (en) * 1996-12-20 2000-02-01 Financial Services Technology Consortium Method and system for processing electronic documents
US6024699A (en) * 1998-03-13 2000-02-15 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients
US6035230A (en) * 1995-09-13 2000-03-07 Medison Co., Ltd Real-time biological signal monitoring system using radio communication network
US6117073A (en) * 1998-03-02 2000-09-12 Jones; Scott J. Integrated emergency medical transportation database system
US6227371B1 (en) * 2000-05-12 2001-05-08 Julie Song Medical container and system
US20020004749A1 (en) * 2000-02-09 2002-01-10 Froseth Barrie R. Customized food selection, ordering and distribution system and method
US20020016719A1 (en) * 2000-06-19 2002-02-07 Nemeth Louis G. Methods and systems for providing medical data to a third party in accordance with configurable distribution parameters
US20020019784A1 (en) * 1999-05-12 2002-02-14 Airclic, Inc. Printed medium activated interactive communication
US20020023172A1 (en) * 2000-07-25 2002-02-21 Gendron David Pierre Routing medical images within a computer network
US20020026111A1 (en) * 2000-08-28 2002-02-28 Neil Ackerman Methods of monitoring glucose levels in a subject and uses thereof
US20020027164A1 (en) * 2000-09-07 2002-03-07 Mault James R. Portable computing apparatus particularly useful in a weight management program
US20020032580A1 (en) * 2000-04-27 2002-03-14 Hopkins John W. Method of directing patients to medical care
US20020032582A1 (en) * 2000-09-14 2002-03-14 Feeney Robert J. System for medication dispensing and integrated data management
US20020032620A1 (en) * 1999-09-24 2002-03-14 Benz Patrick H. Electronic network based controlled products selling and delivering system and method
US20020032583A1 (en) * 1999-12-18 2002-03-14 Joao Raymond Anthony Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
US20020038392A1 (en) * 1999-10-22 2002-03-28 Carlos De La Huerga Method and apparatus for controlling an infusion pump or the like
US20020049738A1 (en) * 2000-08-03 2002-04-25 Epstein Bruce A. Information collaboration and reliability assessment
US20020046948A1 (en) * 2000-05-11 2002-04-25 Chow Andrea W. Microfluidic devices and methods to regulate hydrodynamic and electrical resistance utilizing bulk viscosity enhancers
US6383136B1 (en) * 2000-03-06 2002-05-07 Charlyn Jordan Health analysis and forecast of abnormal conditions
US20020055856A1 (en) * 2000-10-20 2002-05-09 Adams William M. Adjudicating pharmaceutical drug sample distribution system and method
US20020059030A1 (en) * 2000-07-17 2002-05-16 Otworth Michael J. Method and apparatus for the processing of remotely collected electronic information characterizing properties of biological entities
US20020065682A1 (en) * 1999-05-18 2002-05-30 David M. Goldenberg Virtual doctor interactive cybernet system
US20020128259A1 (en) * 2000-10-04 2002-09-12 Maha Ghazzi Treatment of pulmonary hypertension
US20030004403A1 (en) * 2001-06-29 2003-01-02 Darrel Drinan Gateway platform for biological monitoring and delivery of therapeutic compounds
US6510430B1 (en) * 1999-02-24 2003-01-21 Acumins, Inc. Diagnosis and interpretation methods and apparatus for a personal nutrition program
US20030019165A1 (en) * 2001-05-25 2003-01-30 Gallant Dennis J. Patient care apparatus and method
US20030028399A1 (en) * 2000-09-25 2003-02-06 Duane Davis Method and system for providing interactive health care services
US20030032868A1 (en) * 2001-07-09 2003-02-13 Henning Graskov Method and system for controlling data information between two portable apparatuses
US20030036683A1 (en) * 2000-05-01 2003-02-20 Kehr Bruce A. Method, system and computer program product for internet-enabled, patient monitoring system
US6529446B1 (en) * 1996-12-20 2003-03-04 Telaric L.L.C. Interactive medication container
US20030055531A1 (en) * 1995-10-18 2003-03-20 Telepharmacy Solutions, Incorporated Method for controlling a drug dispensing system
US20030061123A1 (en) * 2000-02-04 2003-03-27 Mcmenimen James L. Responsive manufacturing and inventory control
US6541478B1 (en) * 1996-03-13 2003-04-01 Yale University Smoking cessation treatments using naltrexone and related compounds
US20030069757A1 (en) * 2001-10-05 2003-04-10 Sanford Greenberg Systems and methods for designing and delivering a nutritional supplement regime
US20030072770A1 (en) * 1996-08-09 2003-04-17 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US20030086338A1 (en) * 2001-11-08 2003-05-08 Sastry Srikonda V. Wireless web based drug compliance system
US20030092039A1 (en) * 2001-08-01 2003-05-15 Third Wave Technologies, Inc. Screening nutraceuticals
US20030137067A1 (en) * 2001-10-12 2003-07-24 Elan Pharma International Ltd. Compositions having a combination of immediate release and controlled release characteristics
US20030194350A1 (en) * 2002-04-11 2003-10-16 Siemens Information And Communication Networks Public health threat surveillance system
US20040001874A1 (en) * 2002-06-24 2004-01-01 Vital Living, Inc. Safe and effective nutritional supplement formulations and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods
US20040026447A1 (en) * 2002-08-08 2004-02-12 Jeffrey Badin Any protein and energy powder supplement cold dispensing coin operated vending machine
US20040032330A1 (en) * 2002-08-14 2004-02-19 Ncr Corporation Pharmacy transaction system and method
US20040039599A1 (en) * 2001-04-11 2004-02-26 Fralic Donald R. Method of distributing cost savings to participants in a prescription drug distribution chain
US6699193B2 (en) * 2000-09-29 2004-03-02 New Health Sciences, Inc. Decision support systems and methods for assessing vascular health
US20040075272A1 (en) * 2002-10-16 2004-04-22 Kaufman Stacy R. Verification of prescription information with double side extended tab label and method of forming same
US20040078236A1 (en) * 1999-10-30 2004-04-22 Medtamic Holdings Storage and access of aggregate patient data for analysis
US6764831B2 (en) * 1998-11-23 2004-07-20 Proteome Sciences, Inc. Methods and compositions for pain management
US20050010416A1 (en) * 2003-07-09 2005-01-13 Gensym Corporation System and method for self management of health using natural language interface
US20050033121A1 (en) * 2001-12-28 2005-02-10 Modrovich Ivan E. Diagnostic information systems
US20050038558A1 (en) * 2003-05-30 2005-02-17 Keene Astrid I.-S. System and method for labeling pharmaceutical prescriptions
US20050062238A1 (en) * 2003-03-28 2005-03-24 Laird Broadfield Point of care station
US20050070607A1 (en) * 2003-08-19 2005-03-31 James Andrus N-acetylcysteine compositions and methods for the treatment and prevention of cysteine/glutathione deficiency in diseases and conditions
US20050075794A1 (en) * 2001-10-16 2005-04-07 Hoffman Mark A. Computerized method and system for inferring genetic findings for a patient
US6878755B2 (en) * 2001-01-22 2005-04-12 Microgen Systems, Inc. Automated microfabrication-based biodetector
US20050080651A1 (en) * 2003-10-14 2005-04-14 Morrison Kelly L. System and method for remote processing of pharmacy orders
US20050090718A1 (en) * 1999-11-02 2005-04-28 Dodds W J. Animal healthcare well-being and nutrition
US20050102159A1 (en) * 2003-11-06 2005-05-12 Mondshine Robert B. Computer based risk level monitor and patient compliance method and system
US20050113649A1 (en) * 2003-07-28 2005-05-26 Bergantino Paul V. Method and apparatus for managing a user's health
US20050211768A1 (en) * 2002-10-16 2005-09-29 Stillman Suzanne J Interactive vending system(s) featuring product customization, multimedia, education and entertainment, with business opportunities, models, and methods
US20050228245A1 (en) * 1999-12-17 2005-10-13 Q-Tec Systems Llc Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity
US6955873B1 (en) * 2000-08-04 2005-10-18 Kenneth Blum Diagnosis and treatment system for reward deficiency syndrome (RDS) and related behaviors
US20050267356A1 (en) * 2004-05-28 2005-12-01 Narayanan Ramasubramanian Unified ingestion package and process for patient compliance with prescribed medication regimen
US20060010009A1 (en) * 2004-07-07 2006-01-12 Fangman William L Medication card and system
US7005447B2 (en) * 1999-03-30 2006-02-28 Hormos Nutraceutical Oy Ltd. Food product comprising hydroxymatairesinol
US20060047538A1 (en) * 2004-08-25 2006-03-02 Joseph Condurso System and method for dynamically adjusting patient therapy
US7016752B1 (en) * 1999-12-17 2006-03-21 Rxperts, Inc. Method of and system for labeling containers of prescribed medicine
US7029441B2 (en) * 1999-10-15 2006-04-18 Hemopet Animal healthcare, well-being and nutrition
US20060089542A1 (en) * 2004-10-25 2006-04-27 Safe And Sound Solutions, Inc. Mobile patient monitoring system with automatic data alerts
US20060090765A1 (en) * 2004-10-29 2006-05-04 Surina Blake J Method for adjusting metabolic related parameters according to a subject's body weight
US20060099310A1 (en) * 2004-11-10 2006-05-11 Ralph Koekkoek Personalized nutritional supplement
US7135616B2 (en) * 2001-04-18 2006-11-14 Mendel Biotechnology, Inc. Biochemistry-related polynucleotides and polypeptides in plants
US20070018810A1 (en) * 2005-07-20 2007-01-25 Smythe Alan H Radio frequency identification and tagging for implantable medical devices and medical device systems
US7169432B2 (en) * 2004-03-04 2007-01-30 Microsoy Corporation Toasted soybean flakes and method of making same
US7172897B2 (en) * 2000-01-11 2007-02-06 Clinical Micro Sensors, Inc. Devices and methods for biochip multiplexing
US20070035403A1 (en) * 2005-08-12 2007-02-15 Krishna Sudhir S Method and system of personal healthcare management
US7193128B2 (en) * 1997-06-03 2007-03-20 Chromatin, Inc. Methods for generating or increasing revenues from crops
US20070065506A1 (en) * 2005-03-11 2007-03-22 Kelly Robert J Keratin and soluble derivatives thereof for a nutraceutical and to reduce oxidative stress and to reduce inflammation and to promote skin health
US20070067186A1 (en) * 2005-09-22 2007-03-22 Ira Brenner Method and system for electronically prescribing medications
US7197492B2 (en) * 2000-11-02 2007-03-27 Daniel Joseph Sullivan Computerized risk management module for medical diagnosis
US20070068959A1 (en) * 2003-11-26 2007-03-29 D Silva Joe Preparing for individualized dosage forms of medicaments
US20070087048A1 (en) * 2001-05-31 2007-04-19 Abrams Andrew L Oral dosage combination pharmaceutical packaging
US20070093448A1 (en) * 2005-04-13 2007-04-26 Juergen Westermann Complexes that consist of vitamin D compounds or analogs thereof with a 5Z,7E,10(19)-triene system and methylated derivatives of beta-cyclodextrin
US7216343B2 (en) * 2002-09-20 2007-05-08 International Business Machines Corporation Method and apparatus for automatic updating and testing of software
US7280975B1 (en) * 2000-07-24 2007-10-09 Donner Irah H System and method for determining and/or transmitting and/or establishing communication with a mobile device user for providing, for example, concessions, tournaments, competitions, matching, reallocating, upgrading, selling tickets, other event admittance means, goods and/or services
US7351739B2 (en) * 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
US20080097784A1 (en) * 2006-07-17 2008-04-24 Walgreen Co. Appropriateness Of A Medication Therapy Regimen
US7376585B2 (en) * 2002-09-04 2008-05-20 Sap Aktiengesellschaft Real-time sales information architecture
US7379167B2 (en) * 2003-02-11 2008-05-27 International Technidyne Corporation Hemoglobin test strip and analysis system
US7483839B2 (en) * 1994-10-28 2009-01-27 Cybear, L.L.C. Computerized prescription system for gathering and presenting information relating to pharmaceuticals
US7490085B2 (en) * 2002-12-18 2009-02-10 Ge Medical Systems Global Technology Company, Llc Computer-assisted data processing system and method incorporating automated learning
US7502666B2 (en) * 2004-05-14 2009-03-10 Mts Medication Technologies, Inc. Systems and methods for storing and dispensing medication
US20100081144A1 (en) * 2005-05-09 2010-04-01 Theranos, Inc. Point-of-care fluidic systems and uses thereof

Family Cites Families (159)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293845A (en) 1980-04-17 1981-10-06 Villa Real Antony Euclid C Electronic multi-patient medication-time-intake programmer and alarm system
US5054493A (en) 1986-01-31 1991-10-08 Regents Of The University Of Minnesota Method for diagnosing, monitoring and treating hypertension
US4857716A (en) 1986-05-12 1989-08-15 Clinicom Incorporated Patient identification and verification system and method
US6468805B1 (en) 1990-10-10 2002-10-22 Chimera Research And Chemical Inc. Automated analyzer testing of urine for presence of a pH abnormality
US5324077A (en) 1990-12-07 1994-06-28 Kessler Woodrow B Medical data draft for tracking and evaluating medical treatment
SE500122C2 (en) 1992-08-27 1994-04-18 Rudolf Valentin Sillen Method and apparatus for individually controlled, adaptive medication
WO2001037174A1 (en) 1992-11-17 2001-05-25 Health Hero Network, Inc. Method and system for improving adherence with a diet program or other medical regimen
US5940801A (en) 1994-04-26 1999-08-17 Health Hero Network, Inc. Modular microprocessor-based diagnostic measurement apparatus and method for psychological conditions
US5307263A (en) * 1992-11-17 1994-04-26 Raya Systems, Inc. Modular microprocessor-based health monitoring system
WO1994025927A2 (en) 1993-04-30 1994-11-10 Hever For Life For Health For Spirit Ltd. Personalized method and system for storage, communication, analysis and processing of health-related data
US5537313A (en) * 1993-11-22 1996-07-16 Enterprise Systems, Inc. Point of supply use distribution process and apparatus
US5692502A (en) 1995-09-11 1997-12-02 Alpert; Scott E. Computer-aided drug recognition screeening evaluation system and method
US8850477B2 (en) 1995-10-02 2014-09-30 Starsight Telecast, Inc. Systems and methods for linking television viewers with advertisers and broadcasters
ATE333880T1 (en) 1995-10-24 2006-08-15 Gruenenthal Gmbh MONTIRELIN TO PREVENT SLEEP APNEA
US5700998A (en) 1995-10-31 1997-12-23 Palti; Yoram Drug coding and delivery system
US5807579A (en) 1995-11-16 1998-09-15 F.H. Faulding & Co. Limited Pseudoephedrine combination pharmaceutical compositions
US5995938A (en) 1996-02-27 1999-11-30 Whaley; Susan S. Medication compliance system
US6108635A (en) * 1996-05-22 2000-08-22 Interleukin Genetics, Inc. Integrated disease information system
US5955269A (en) 1996-06-20 1999-09-21 Rutgers, The State University Of New Jersey Methods of screening foods for nutraceuticals
US5954640A (en) 1996-06-27 1999-09-21 Szabo; Andrew J. Nutritional optimization method
US5770226A (en) * 1996-07-10 1998-06-23 Wake Forest University Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
US5798266A (en) 1996-08-27 1998-08-25 K-Quay Enterprises, Llc Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer
US8734339B2 (en) * 1996-12-16 2014-05-27 Ip Holdings, Inc. Electronic skin patch for real time monitoring of cardiac activity and personal health management
CN1252877A (en) 1997-03-13 2000-05-10 第一咨询公司 Disease management system
US5985214A (en) 1997-05-16 1999-11-16 Aurora Biosciences Corporation Systems and methods for rapidly identifying useful chemicals in liquid samples
US6139494A (en) 1997-10-15 2000-10-31 Health Informatics Tools Method and apparatus for an integrated clinical tele-informatics system
AU2638199A (en) 1998-03-02 1999-09-20 Biosensing Technologies Ltd. Luminescent microbe assay
US6421650B1 (en) 1998-03-04 2002-07-16 Goetech Llc Medication monitoring system and apparatus
US6801916B2 (en) 1998-04-01 2004-10-05 Cyberpulse, L.L.C. Method and system for generation of medical reports from data in a hierarchically-organized database
BR9909906A (en) * 1998-04-03 2000-12-26 Triangle Pharmaceuticals Inc Computer program systems, methods and products to guide the selection of therapeutic treatment regimens
US6287595B1 (en) 1998-06-10 2001-09-11 Delsys Pharmaceuticals Corporation Biomedical assay device
US6128534A (en) 1998-06-16 2000-10-03 Pacesetter, Inc. Implantable cardiac stimulation device and method for varying pacing parameters to mimic circadian cycles
US6397190B1 (en) * 1998-07-22 2002-05-28 Gerald E. Goetz Veterinary medication monitoring system and apparatus
US6735593B1 (en) * 1998-11-12 2004-05-11 Simon Guy Williams Systems and methods for storing data
US6161095A (en) 1998-12-16 2000-12-12 Health Hero Network, Inc. Treatment regimen compliance and efficacy with feedback
NZ513538A (en) * 1999-02-03 2004-02-27 Powderject Res Ltd Pharmaceutical composition associated with hydrogel particles for administration by transdermal delivery from a needless syringe
US7418399B2 (en) 1999-03-10 2008-08-26 Illinois Institute Of Technology Methods and kits for managing diagnosis and therapeutics of bacterial infections
WO2000060362A1 (en) 1999-04-08 2000-10-12 Chung Chang Young Apparatus for fast preparation and analysis of nucleic acids
US6692916B2 (en) 1999-06-28 2004-02-17 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US6372895B1 (en) 2000-07-07 2002-04-16 3M Innovative Properties Company Fluorogenic compounds
US6827260B2 (en) 1999-08-09 2004-12-07 First Data Corporation Systems and methods for utilizing a point-of-sale system
US6671818B1 (en) 1999-11-22 2003-12-30 Accenture Llp Problem isolation through translating and filtering events into a standard object format in a network based supply chain
US7136820B1 (en) 1999-11-22 2006-11-14 Advanced Medical Instruments Method/process of determining a personal dietary supplement profile and recommending dietary supplements for an individual
US6790198B1 (en) 1999-12-01 2004-09-14 B-Braun Medical, Inc. Patient medication IV delivery pump with wireless communication to a hospital information management system
US7645258B2 (en) 1999-12-01 2010-01-12 B. Braun Medical, Inc. Patient medication IV delivery pump with wireless communication to a hospital information management system
US6980958B1 (en) 2000-01-11 2005-12-27 Zycare, Inc. Apparatus and methods for monitoring and modifying anticoagulation therapy of remotely located patients
US20010037340A1 (en) 2000-02-07 2001-11-01 Daniel Hawkins System and method for providing medical services and administering medical protocols to individuals based upon biological testing
AU2001235284A1 (en) 2000-02-22 2001-09-03 Cellegy Canada Inc. Methods and compositions for improving sleep
WO2001079529A1 (en) 2000-04-17 2001-10-25 Purdue Research Foundation Biosensor and related method
US20010039503A1 (en) 2000-04-28 2001-11-08 Chan Bryan K. Method and system for managing chronic disease and wellness online
US6898761B2 (en) * 2000-05-01 2005-05-24 Raytheon Company Extensible markup language genetic algorithm
US6988989B2 (en) 2000-05-19 2006-01-24 Welch Allyn Protocol, Inc. Patient monitoring system
US20040078220A1 (en) * 2001-06-14 2004-04-22 Jackson Becky L. System and method for collection, distribution, and use of information in connection with health care delivery
US8688474B2 (en) 2000-06-26 2014-04-01 Epic Systems Corporation Patient health record access system
AU2001270257A1 (en) * 2000-06-28 2002-01-08 Healthangel.Com, Inc. System for prompting user activities
AU2001277277A1 (en) 2000-07-27 2002-04-02 Network Disease Managment, Inc. Method and apparatus for analyzing a patient medical information database to identify patients likely to experience a problematic disease transition
US20050027570A1 (en) 2000-08-11 2005-02-03 Maier Frith Ann Digital image collection and library system
US6450956B1 (en) * 2000-11-06 2002-09-17 Siemens Corporate Research, Inc. System and method for treatment and outcome measurement analysis
US7273629B2 (en) 2000-11-28 2007-09-25 Cryovac, Inc. Meat package with reduced leaker rates
US6497342B2 (en) 2000-11-30 2002-12-24 Mckesson Automated Healthcare, Inc. Medicine feeder
US20030082544A1 (en) 2001-07-11 2003-05-01 Third Wave Technologies, Inc. Methods and systems for validating detection assays, developing in-vitro diagnostic DNA or RNA analysis products, and increasing revenue and/or profit margins from in-vitro diagnostic DNA or RNA analysis assays
US20030233124A1 (en) 2000-12-18 2003-12-18 Hajuku Institute For Health Science Co., Ltd. Methods of treating disorders by altering ion flux across cell membranes with electric fields
US20020091546A1 (en) * 2001-01-11 2002-07-11 University Of Washington Point of care
US20020192310A1 (en) 2001-02-02 2002-12-19 Bland Jeffrey S. Medical composition for managing hormone balance
US20020116225A1 (en) 2001-02-15 2002-08-22 Margaret Morse Tracking and reporting client outcome
US6888095B2 (en) 2001-02-28 2005-05-03 Sherwood Technology, Inc. Laser coding
US20020143434A1 (en) 2001-03-29 2002-10-03 John Greeven Method and apparatus for delivering and refilling pharmaceuticals
US7359518B2 (en) 2001-04-05 2008-04-15 Intel Corporation Distribution of secured information
US20020156651A1 (en) 2001-04-18 2002-10-24 Florio Vito V. Prescription system for unregulated therapeutic substances
US7038588B2 (en) 2001-05-04 2006-05-02 Draeger Medical Infant Care, Inc. Apparatus and method for patient point-of-care data management
US20020194221A1 (en) 2001-05-07 2002-12-19 Strong Philip C. System, method and computer program product for collecting information utilizing an extensible markup language (XML) framework
WO2003003267A1 (en) 2001-06-29 2003-01-09 Nutrition Act.Co., Ltd. Nutrition demand calculating apparatus, nutrition supplementary ingredient proposing apparatus, nutrition supplementary ingredient blending apparatus, and nutrition supplementary ingredient blending system
WO2003003162A2 (en) 2001-06-29 2003-01-09 Clinomics Biosciences, Inc. Evaluating neuropsychiatric diseases using a specimen-linked database
US20030010791A1 (en) 2001-07-13 2003-01-16 Andrew Gentiluomo Method and apparatus for dispensing a customized pharamaceutical mixture
US7529685B2 (en) 2001-08-28 2009-05-05 Md Datacor, Inc. System, method, and apparatus for storing, retrieving, and integrating clinical, diagnostic, genomic, and therapeutic data
US7461006B2 (en) 2001-08-29 2008-12-02 Victor Gogolak Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data
US6966880B2 (en) 2001-10-16 2005-11-22 Agilent Technologies, Inc. Universal diagnostic platform
CA2463741A1 (en) 2001-10-22 2003-05-01 Merck & Co., Inc. Interactive product selection system
AU2002348135A1 (en) * 2001-10-31 2003-05-12 Recovery Pharmaceuticals, Inc. Methods for the treatment of addiction
US20050101841A9 (en) * 2001-12-04 2005-05-12 Kimberly-Clark Worldwide, Inc. Healthcare networks with biosensors
WO2003061453A2 (en) 2001-12-04 2003-07-31 Lifepoint, Inc. Device and method for the identification of analytes in bodily fluids
CA2469940A1 (en) * 2001-12-19 2003-06-26 Takeda Chemical Industries, Ltd. Solid compositions comprising compounds unstable to oxygen and method for stabilizing them
FI20021031A (en) 2001-12-28 2003-06-29 Pertti Laehteenmaeki Nutritional Machine
US7877273B2 (en) 2002-01-08 2011-01-25 Fredric David Abramson System and method for evaluating and providing nutrigenomic data, information and advice
US6985870B2 (en) 2002-01-11 2006-01-10 Baxter International Inc. Medication delivery system
US7490047B2 (en) * 2002-01-22 2009-02-10 Medco Health Solutions, Inc. Apparatus and method for constructing formularies
US20030163353A1 (en) 2002-01-25 2003-08-28 Bryan Luce Method and system for patient preference determination for treatment options
US8489427B2 (en) * 2002-01-29 2013-07-16 Baxter International Inc. Wireless medical data communication system and method
US20040084895A1 (en) 2002-10-19 2004-05-06 Harvey Blum System for reducing health-insurance costs including fraud by providing medical histories
AU2003213123A1 (en) 2002-02-19 2003-09-09 Lexicor Medical Technology, Inc. Systems and methods for managing biological data and providing data interpretation tools
US20030204412A1 (en) 2002-04-29 2003-10-30 John Brier Apparatus and method for providing on-line customized nutrition, fitness, and lifestyle plans based upon a user profile and goals
US6833274B2 (en) 2002-05-28 2004-12-21 The Johns Hopkins University Cortisol sensor
US20030233257A1 (en) 2002-06-13 2003-12-18 Gregor Matian Interactive patient data report generation
CA2490284C (en) 2002-06-21 2013-10-22 Mckesson Information Solutions Llc Closed loop medication use system and method
DE10228680A1 (en) 2002-06-27 2004-01-22 Holden Development Limited, Tortola Basis for transdermal formulations (PTF)
US7759395B2 (en) 2002-08-12 2010-07-20 The Brigham And Women's Hospital, Inc. Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma
CN1701343A (en) 2002-09-20 2005-11-23 德克萨斯大学董事会 Computer program products, systems and methods for information discovery and relational analyses
US20040064342A1 (en) * 2002-09-30 2004-04-01 Browne David W. Health care protocols
WO2004036182A2 (en) 2002-10-17 2004-04-29 Control Delivery Systems, Inc. Methods for monitoring treatment of disease
US20050271596A1 (en) 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US6730333B1 (en) 2002-10-30 2004-05-04 Dbc, Llc Nutraceutical mangosteen composition
US7860724B2 (en) * 2002-10-30 2010-12-28 Automed Technologies, Inc. System and method for management of pharmacy workflow
US20040088374A1 (en) 2002-10-31 2004-05-06 Webb James D. Aggregation and sharing of patient data
US20040143403A1 (en) 2002-11-14 2004-07-22 Brandon Richard Bruce Status determination
US20040111298A1 (en) * 2002-12-10 2004-06-10 Roy Schoenberg Method of and system for integrating health information into a patient's record
US20040122707A1 (en) * 2002-12-18 2004-06-24 Sabol John M. Patient-driven medical data processing system and method
US20040122661A1 (en) * 2002-12-23 2004-06-24 Gensym Corporation Method, system, and computer program product for storing, managing and using knowledge expressible as, and organized in accordance with, a natural language
US20040220498A1 (en) 2003-01-24 2004-11-04 Guann-Pyng Li Micro medical-lab-on-a-chip in a lollipop as a drug delivery device and/or a health monitoring device
WO2004069156A2 (en) 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
JP4723476B2 (en) 2003-02-14 2011-07-13 チルドレンズ ホスピタル アンド リサーチ センター アット オークランド Treatment of conditions associated with reduced nitric oxide bioavailability, including elevated arginase status
US20050014134A1 (en) 2003-03-06 2005-01-20 West Jason Andrew Appleton Viral identification by generation and detection of protein signatures
US7469213B1 (en) 2003-03-14 2008-12-23 Secure Medical, Inc. Prescription drug distribution system and methods
US20050038674A1 (en) * 2003-04-15 2005-02-17 Braig James R. System and method for managing a chronic medical condition
US20040243441A1 (en) 2003-04-15 2004-12-02 Siegfried Bocionek Personal and healthcare data financial management system
US20040215486A1 (en) 2003-04-23 2004-10-28 Medi-Dose, Inc. Prescription labeling system and method of use
US20040225203A1 (en) 2003-05-06 2004-11-11 Jemison Mae C. Real-time and simultaneous monitoring of multiple parameters from multiple living beings
US20040243437A1 (en) 2003-05-30 2004-12-02 Grace Joseph P. Compensated electronic consults
ATE481101T1 (en) 2003-06-10 2010-10-15 Kyowa Hakko Kirin Co Ltd METHOD FOR TREATING ANXIETY
US7548886B2 (en) 2003-06-12 2009-06-16 International Business Machines Corporation System and method for early detection and prevention of identity theft
EP2324828A1 (en) 2003-08-18 2011-05-25 BTG International Limited Treatment for neurodegenerative conditions
US7312243B1 (en) 2003-08-29 2007-12-25 Jay Pravda Materials and methods for treatment of gastrointestinal disorders
EP1671253A2 (en) 2003-09-24 2006-06-21 Medtronic, Inc. Apparatus and method for serving medical device application content to a remote computing device
EP1682063A1 (en) 2003-10-21 2006-07-26 Ambo Innovation LLC Digestible and volume adjustable multi medication delivery device
US20060111944A1 (en) * 2003-10-31 2006-05-25 Sirmans James R Jr System and method for encouraging performance of health-promoting measures
US20050111944A1 (en) * 2003-11-25 2005-05-26 Marc Aho Compact wafer handling system with single axis robotic arm and prealigner-cassette elevator
WO2005062849A2 (en) 2003-12-19 2005-07-14 Elixir Pharmaceuticals, Inc. Lifespan management
US20050149354A1 (en) 2004-01-02 2005-07-07 Cyr Keneth K. System and method for management of clinical supply operations
US20050147667A1 (en) 2004-01-06 2005-07-07 Rines Robert H. Method of ensuring patient identification of prescribed drug and quantity for prescribed purpose and improved self-identifying drug appearance
US20050240085A1 (en) 2004-01-16 2005-10-27 Basf Aktiengesellschaft Balanced care product customization
US8815536B2 (en) 2004-02-04 2014-08-26 The Johns Hopkins University Methods and systems for sampling, screening, and diagnosis
US20070118054A1 (en) 2005-11-01 2007-05-24 Earlysense Ltd. Methods and systems for monitoring patients for clinical episodes
US20050182653A1 (en) * 2004-02-12 2005-08-18 Joseph Urban System and method for improving and promoting compliance to a therapeutic regimen
US20050192487A1 (en) 2004-02-27 2005-09-01 Cosentino Louis C. System for collection, manipulation, and analysis of data from remote health care devices
AU2005227313A1 (en) 2004-03-19 2005-10-06 Amgen Inc. Reducing the risk of human and anti-human antibodies through V gene manipulation
US20050216390A1 (en) 2004-03-23 2005-09-29 Snider Kimberly A System and method of managing a position in financial stock investments
US20050216313A1 (en) 2004-03-26 2005-09-29 Ecapable, Inc. Method, device, and systems to facilitate identity management and bidirectional data flow within a patient electronic record keeping system
US8135595B2 (en) 2004-05-14 2012-03-13 H. Lee Moffitt Cancer Center And Research Institute, Inc. Computer systems and methods for providing health care
US20050260610A1 (en) 2004-05-20 2005-11-24 Kurtz Richard E Method for diagnosing and prescribing a regimen of therapy for human health risk
US7433853B2 (en) 2004-07-12 2008-10-07 Cardiac Pacemakers, Inc. Expert system for patient medical information analysis
US7409297B2 (en) * 2004-09-17 2008-08-05 Bionutritional, Llc Methods and systems for providing a nutraceutical program specific to an individual animal
US20060073099A1 (en) 2004-10-01 2006-04-06 Frincke James M Treatment screening methods
US20060129324A1 (en) * 2004-12-15 2006-06-15 Biogenesys, Inc. Use of quantitative EEG (QEEG) alone and/or other imaging technology and/or in combination with genomics and/or proteomics and/or biochemical analysis and/or other diagnostic modalities, and CART and/or AI and/or statistical and/or other mathematical analysis methods for improved medical and other diagnosis, psychiatric and other disease treatment, and also for veracity verification and/or lie detection applications.
US20060136259A1 (en) * 2004-12-17 2006-06-22 General Electric Company Multi-dimensional analysis of medical data
US20060161443A1 (en) 2005-01-14 2006-07-20 Lladnar Technology Co, Llc Systems and methods for collecting and managing animal-related information
JP4548316B2 (en) 2005-02-10 2010-09-22 セイコーエプソン株式会社 Color ID card, card creation system, card creation method, program, and storage medium
EP1690559A1 (en) 2005-02-14 2006-08-16 Ares Trading S.A. Medication delivery device
US8968806B2 (en) 2005-04-26 2015-03-03 Sean Joseph Delaney Method and system for creating and using a supplement to balance animal diets
US20060248468A1 (en) 2005-04-29 2006-11-02 Larry Constantine Apparatus and method for controlling visibility of data with visual nesting
JP4596976B2 (en) 2005-05-20 2010-12-15 株式会社 日立ディスプレイズ Organic light emitting display
US20060287891A1 (en) 2005-06-16 2006-12-21 Cerner Innovation, Inc. System and method in a computerized environment for charting pediatric growth
WO2007016931A1 (en) 2005-07-25 2007-02-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Chip-holder for a micro-fluidic chip
EP1952320A2 (en) 2005-11-17 2008-08-06 Searete LLC. Assistance related to health
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20070192134A1 (en) 2005-12-15 2007-08-16 Benjamin Littenberg Clinical decision support system
US20080100279A1 (en) 2006-06-15 2008-05-01 University Of South Florida Nano-Based Device for Detection of Disease Biomarkers and Other Target Molecules
EP1933246A1 (en) 2006-12-14 2008-06-18 F.Hoffmann-La Roche Ag A method for visualising a chronological sequence of measurements
US7957984B1 (en) 2007-02-28 2011-06-07 Anthony Vallone Device for facilitating compliance with medication regimen
US7844609B2 (en) 2007-03-16 2010-11-30 Expanse Networks, Inc. Attribute combination discovery
US7454880B1 (en) 2007-05-31 2008-11-25 Xerox Corporation Personalized medication packaging

Patent Citations (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446138A (en) * 1982-02-10 1984-05-01 Pack Howard M Method and composition for reducing weight
US4567185A (en) * 1983-05-13 1986-01-28 Key Pharmaceuticals, Inc. Endorphin blockage
US5279294A (en) * 1985-04-08 1994-01-18 Cascade Medical, Inc. Medical diagnostic system
US4838275A (en) * 1985-11-29 1989-06-13 Lee Arnold St J Home medical surveillance system
US4847764C1 (en) * 1987-05-21 2001-09-11 Meditrol Inc System for dispensing drugs in health care instituions
US4847764A (en) * 1987-05-21 1989-07-11 Meditrol, Inc. System for dispensing drugs in health care institutions
US5710578A (en) * 1987-12-09 1998-01-20 International Business Machines Corporation Computer program product for utilizing fast polygon fill routines in a graphics display system
US5300302A (en) * 1990-10-04 1994-04-05 Nestec S.A. Pharmaceutical composition in gel form in a dispensing package
US5176285A (en) * 1991-08-26 1993-01-05 Shaw Thomas J Pill dispensing apparatus
US5495961A (en) * 1992-03-30 1996-03-05 Maestre; Federico A. Portable programmable medication alarm device and method and apparatus for programming and using the same
US7483839B2 (en) * 1994-10-28 2009-01-27 Cybear, L.L.C. Computerized prescription system for gathering and presenting information relating to pharmaceuticals
US5737539A (en) * 1994-10-28 1998-04-07 Advanced Health Med-E-Systems Corp. Prescription creation system
US5758096A (en) * 1995-08-09 1998-05-26 Barsky; Howard System and method for personalized medication treatment management
US6035230A (en) * 1995-09-13 2000-03-07 Medison Co., Ltd Real-time biological signal monitoring system using radio communication network
US20030088333A1 (en) * 1995-10-18 2003-05-08 Telepharmacy Solutions, Incorporated Method for controlling a drug dispensing system
US20030055531A1 (en) * 1995-10-18 2003-03-20 Telepharmacy Solutions, Incorporated Method for controlling a drug dispensing system
US20030074218A1 (en) * 1995-10-18 2003-04-17 Liff Harold J. Method for controlling a drug dispensing system
US20050065645A1 (en) * 1995-10-18 2005-03-24 Telepharmacy Solutions, Incorporated Method for controlling a drug dispensing system
US6541478B1 (en) * 1996-03-13 2003-04-01 Yale University Smoking cessation treatments using naltrexone and related compounds
US20030072770A1 (en) * 1996-08-09 2003-04-17 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US6021202A (en) * 1996-12-20 2000-02-01 Financial Services Technology Consortium Method and system for processing electronic documents
US6529446B1 (en) * 1996-12-20 2003-03-04 Telaric L.L.C. Interactive medication container
US20030099158A1 (en) * 1996-12-20 2003-05-29 Carlos De La Huerga Interactive medication container
US5873369A (en) * 1997-03-31 1999-02-23 Chronoslim P.C.E. Ltd. System for monitoring health conditions of an individual and a method thereof
US7193128B2 (en) * 1997-06-03 2007-03-20 Chromatin, Inc. Methods for generating or increasing revenues from crops
US5907291A (en) * 1997-06-05 1999-05-25 Vsm Technology Inc. Multi-patient monitoring apparatus and method
US5882931A (en) * 1997-07-14 1999-03-16 Petersen; Roger Method and apparatus for performing urinalysis in real time
US6117073A (en) * 1998-03-02 2000-09-12 Jones; Scott J. Integrated emergency medical transportation database system
US6024699A (en) * 1998-03-13 2000-02-15 Healthware Corporation Systems, methods and computer program products for monitoring, diagnosing and treating medical conditions of remotely located patients
US6764831B2 (en) * 1998-11-23 2004-07-20 Proteome Sciences, Inc. Methods and compositions for pain management
US6510430B1 (en) * 1999-02-24 2003-01-21 Acumins, Inc. Diagnosis and interpretation methods and apparatus for a personal nutrition program
US7005447B2 (en) * 1999-03-30 2006-02-28 Hormos Nutraceutical Oy Ltd. Food product comprising hydroxymatairesinol
US20020019784A1 (en) * 1999-05-12 2002-02-14 Airclic, Inc. Printed medium activated interactive communication
US20020065682A1 (en) * 1999-05-18 2002-05-30 David M. Goldenberg Virtual doctor interactive cybernet system
US20020032620A1 (en) * 1999-09-24 2002-03-14 Benz Patrick H. Electronic network based controlled products selling and delivering system and method
US7029441B2 (en) * 1999-10-15 2006-04-18 Hemopet Animal healthcare, well-being and nutrition
US20020038392A1 (en) * 1999-10-22 2002-03-28 Carlos De La Huerga Method and apparatus for controlling an infusion pump or the like
US20040078236A1 (en) * 1999-10-30 2004-04-22 Medtamic Holdings Storage and access of aggregate patient data for analysis
US20050090718A1 (en) * 1999-11-02 2005-04-28 Dodds W J. Animal healthcare well-being and nutrition
US20050228245A1 (en) * 1999-12-17 2005-10-13 Q-Tec Systems Llc Method and apparatus for health and disease management combining patient data monitoring with wireless internet connectivity
US7016752B1 (en) * 1999-12-17 2006-03-21 Rxperts, Inc. Method of and system for labeling containers of prescribed medicine
US20020032583A1 (en) * 1999-12-18 2002-03-14 Joao Raymond Anthony Apparatus and method for processing and/or for providing healthcare information and/or healthcare-related information
US7172897B2 (en) * 2000-01-11 2007-02-06 Clinical Micro Sensors, Inc. Devices and methods for biochip multiplexing
US20030061123A1 (en) * 2000-02-04 2003-03-27 Mcmenimen James L. Responsive manufacturing and inventory control
US20020004749A1 (en) * 2000-02-09 2002-01-10 Froseth Barrie R. Customized food selection, ordering and distribution system and method
US6383136B1 (en) * 2000-03-06 2002-05-07 Charlyn Jordan Health analysis and forecast of abnormal conditions
US20020032580A1 (en) * 2000-04-27 2002-03-14 Hopkins John W. Method of directing patients to medical care
US20030036683A1 (en) * 2000-05-01 2003-02-20 Kehr Bruce A. Method, system and computer program product for internet-enabled, patient monitoring system
US20020046948A1 (en) * 2000-05-11 2002-04-25 Chow Andrea W. Microfluidic devices and methods to regulate hydrodynamic and electrical resistance utilizing bulk viscosity enhancers
US6227371B1 (en) * 2000-05-12 2001-05-08 Julie Song Medical container and system
US20020016719A1 (en) * 2000-06-19 2002-02-07 Nemeth Louis G. Methods and systems for providing medical data to a third party in accordance with configurable distribution parameters
US20020059030A1 (en) * 2000-07-17 2002-05-16 Otworth Michael J. Method and apparatus for the processing of remotely collected electronic information characterizing properties of biological entities
US7280975B1 (en) * 2000-07-24 2007-10-09 Donner Irah H System and method for determining and/or transmitting and/or establishing communication with a mobile device user for providing, for example, concessions, tournaments, competitions, matching, reallocating, upgrading, selling tickets, other event admittance means, goods and/or services
US20020023172A1 (en) * 2000-07-25 2002-02-21 Gendron David Pierre Routing medical images within a computer network
US20020049738A1 (en) * 2000-08-03 2002-04-25 Epstein Bruce A. Information collaboration and reliability assessment
US6955873B1 (en) * 2000-08-04 2005-10-18 Kenneth Blum Diagnosis and treatment system for reward deficiency syndrome (RDS) and related behaviors
US20020026111A1 (en) * 2000-08-28 2002-02-28 Neil Ackerman Methods of monitoring glucose levels in a subject and uses thereof
US20020047867A1 (en) * 2000-09-07 2002-04-25 Mault James R Image based diet logging
US20020027164A1 (en) * 2000-09-07 2002-03-07 Mault James R. Portable computing apparatus particularly useful in a weight management program
US20020032582A1 (en) * 2000-09-14 2002-03-14 Feeney Robert J. System for medication dispensing and integrated data management
US20030028399A1 (en) * 2000-09-25 2003-02-06 Duane Davis Method and system for providing interactive health care services
US6699193B2 (en) * 2000-09-29 2004-03-02 New Health Sciences, Inc. Decision support systems and methods for assessing vascular health
US20020128259A1 (en) * 2000-10-04 2002-09-12 Maha Ghazzi Treatment of pulmonary hypertension
US20020055856A1 (en) * 2000-10-20 2002-05-09 Adams William M. Adjudicating pharmaceutical drug sample distribution system and method
US7197492B2 (en) * 2000-11-02 2007-03-27 Daniel Joseph Sullivan Computerized risk management module for medical diagnosis
US6878755B2 (en) * 2001-01-22 2005-04-12 Microgen Systems, Inc. Automated microfabrication-based biodetector
US20040039599A1 (en) * 2001-04-11 2004-02-26 Fralic Donald R. Method of distributing cost savings to participants in a prescription drug distribution chain
US7135616B2 (en) * 2001-04-18 2006-11-14 Mendel Biotechnology, Inc. Biochemistry-related polynucleotides and polypeptides in plants
US20030019165A1 (en) * 2001-05-25 2003-01-30 Gallant Dennis J. Patient care apparatus and method
US20070087048A1 (en) * 2001-05-31 2007-04-19 Abrams Andrew L Oral dosage combination pharmaceutical packaging
US20030004403A1 (en) * 2001-06-29 2003-01-02 Darrel Drinan Gateway platform for biological monitoring and delivery of therapeutic compounds
US20030032868A1 (en) * 2001-07-09 2003-02-13 Henning Graskov Method and system for controlling data information between two portable apparatuses
US20030092039A1 (en) * 2001-08-01 2003-05-15 Third Wave Technologies, Inc. Screening nutraceuticals
US20030069757A1 (en) * 2001-10-05 2003-04-10 Sanford Greenberg Systems and methods for designing and delivering a nutritional supplement regime
US20030137067A1 (en) * 2001-10-12 2003-07-24 Elan Pharma International Ltd. Compositions having a combination of immediate release and controlled release characteristics
US20050075794A1 (en) * 2001-10-16 2005-04-07 Hoffman Mark A. Computerized method and system for inferring genetic findings for a patient
US20030086338A1 (en) * 2001-11-08 2003-05-08 Sastry Srikonda V. Wireless web based drug compliance system
US20050033121A1 (en) * 2001-12-28 2005-02-10 Modrovich Ivan E. Diagnostic information systems
US20030194350A1 (en) * 2002-04-11 2003-10-16 Siemens Information And Communication Networks Public health threat surveillance system
US20040001874A1 (en) * 2002-06-24 2004-01-01 Vital Living, Inc. Safe and effective nutritional supplement formulations and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods
US20040026447A1 (en) * 2002-08-08 2004-02-12 Jeffrey Badin Any protein and energy powder supplement cold dispensing coin operated vending machine
US20040032330A1 (en) * 2002-08-14 2004-02-19 Ncr Corporation Pharmacy transaction system and method
US7376585B2 (en) * 2002-09-04 2008-05-20 Sap Aktiengesellschaft Real-time sales information architecture
US7216343B2 (en) * 2002-09-20 2007-05-08 International Business Machines Corporation Method and apparatus for automatic updating and testing of software
US20050211768A1 (en) * 2002-10-16 2005-09-29 Stillman Suzanne J Interactive vending system(s) featuring product customization, multimedia, education and entertainment, with business opportunities, models, and methods
US20040075272A1 (en) * 2002-10-16 2004-04-22 Kaufman Stacy R. Verification of prescription information with double side extended tab label and method of forming same
US7490085B2 (en) * 2002-12-18 2009-02-10 Ge Medical Systems Global Technology Company, Llc Computer-assisted data processing system and method incorporating automated learning
US7379167B2 (en) * 2003-02-11 2008-05-27 International Technidyne Corporation Hemoglobin test strip and analysis system
US20050062238A1 (en) * 2003-03-28 2005-03-24 Laird Broadfield Point of care station
US20050038558A1 (en) * 2003-05-30 2005-02-17 Keene Astrid I.-S. System and method for labeling pharmaceutical prescriptions
US20050010416A1 (en) * 2003-07-09 2005-01-13 Gensym Corporation System and method for self management of health using natural language interface
US20050113649A1 (en) * 2003-07-28 2005-05-26 Bergantino Paul V. Method and apparatus for managing a user's health
US20050070607A1 (en) * 2003-08-19 2005-03-31 James Andrus N-acetylcysteine compositions and methods for the treatment and prevention of cysteine/glutathione deficiency in diseases and conditions
US20050080651A1 (en) * 2003-10-14 2005-04-14 Morrison Kelly L. System and method for remote processing of pharmacy orders
US20050102159A1 (en) * 2003-11-06 2005-05-12 Mondshine Robert B. Computer based risk level monitor and patient compliance method and system
US20070068959A1 (en) * 2003-11-26 2007-03-29 D Silva Joe Preparing for individualized dosage forms of medicaments
US7169432B2 (en) * 2004-03-04 2007-01-30 Microsoy Corporation Toasted soybean flakes and method of making same
US7351739B2 (en) * 2004-04-30 2008-04-01 Wellgen, Inc. Bioactive compounds and methods of uses thereof
US7502666B2 (en) * 2004-05-14 2009-03-10 Mts Medication Technologies, Inc. Systems and methods for storing and dispensing medication
US20050267356A1 (en) * 2004-05-28 2005-12-01 Narayanan Ramasubramanian Unified ingestion package and process for patient compliance with prescribed medication regimen
US20060010009A1 (en) * 2004-07-07 2006-01-12 Fangman William L Medication card and system
US20060047538A1 (en) * 2004-08-25 2006-03-02 Joseph Condurso System and method for dynamically adjusting patient therapy
US20060089542A1 (en) * 2004-10-25 2006-04-27 Safe And Sound Solutions, Inc. Mobile patient monitoring system with automatic data alerts
US20060090765A1 (en) * 2004-10-29 2006-05-04 Surina Blake J Method for adjusting metabolic related parameters according to a subject's body weight
US20060099310A1 (en) * 2004-11-10 2006-05-11 Ralph Koekkoek Personalized nutritional supplement
US20070065506A1 (en) * 2005-03-11 2007-03-22 Kelly Robert J Keratin and soluble derivatives thereof for a nutraceutical and to reduce oxidative stress and to reduce inflammation and to promote skin health
US20070093448A1 (en) * 2005-04-13 2007-04-26 Juergen Westermann Complexes that consist of vitamin D compounds or analogs thereof with a 5Z,7E,10(19)-triene system and methylated derivatives of beta-cyclodextrin
US20100081144A1 (en) * 2005-05-09 2010-04-01 Theranos, Inc. Point-of-care fluidic systems and uses thereof
US20070018810A1 (en) * 2005-07-20 2007-01-25 Smythe Alan H Radio frequency identification and tagging for implantable medical devices and medical device systems
US20070035403A1 (en) * 2005-08-12 2007-02-15 Krishna Sudhir S Method and system of personal healthcare management
US20070067186A1 (en) * 2005-09-22 2007-03-22 Ira Brenner Method and system for electronically prescribing medications
US20080097784A1 (en) * 2006-07-17 2008-04-24 Walgreen Co. Appropriateness Of A Medication Therapy Regimen

Also Published As

Publication number Publication date
US10042980B2 (en) 2018-08-07
US20070112588A1 (en) 2007-05-17
US20070112587A1 (en) 2007-05-17
WO2007061705A3 (en) 2007-12-13
WO2007061705A2 (en) 2007-05-31

Similar Documents

Publication Publication Date Title
Su A model of consumer inertia with applications to dynamic pricing
US8532938B2 (en) Testing-dependent administration of a nutraceutical
US8412538B2 (en) System and method for prepurchased replenishment of pharmaceuticals
US10734106B2 (en) System and method for filling a prescription
US20200160986A1 (en) Workflow predictive analytics Engine
Yadav et al. The world medicines situation 2011
Temple et al. Implementation and evaluation of carousel dispensing technology in a university medical center pharmacy
Iannone et al. Pulling drugs along the supply chain: centralization of hospitals' inventory
Chokshi et al. A cross-sectional survey of the models in Bihar and Tamil Nadu, India for pooled procurement of medicines
Saha et al. Patient condition-based medicine inventory management in healthcare systems
US20220238215A1 (en) Workflow Predictive Analytics Engine
US11645093B2 (en) Systems and methods for user interface adaptation for per-user metrics
US20200118667A1 (en) Secure System and Method To Produce Customized Nutritional Products
US20070112591A1 (en) Generating a request from a nutraceutical inventory
US20230009804A1 (en) Machine-learning techniques for generating entity instructions
RHIA et al. Best of breed electronic medical record comparative analysis
US20220157433A1 (en) Predictive modeling for mental health management
US20220139518A1 (en) Shipping disruption predictive technology
WO2007061835A2 (en) Generating a request from a nutraceutical inventory
US20070119928A1 (en) Generating a nutraceutical request from an inventory
EP3826029A1 (en) Workflow predictive analytics engine
Sahu et al. Effectiveness of supply chain planning in ensuring availability of CD/NCD drugs in non-metropolitan and rural public health system
Granlund The effect of pharmacies’ right to negotiate discounts on the market share of parallel imported pharmaceuticals
Abouzahra et al. Remaking Rosa Medical Center: a 5-step approach to transitioning with lean
US20220157435A1 (en) Mental health predictive model management system

Legal Events

Date Code Title Description
AS Assignment

Owner name: SEARETE LLC,WASHINGTON

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JUNG, EDWARD K.Y.;LEVIEN, ROYCE A.;LORD, ROBERT W.;AND OTHERS;SIGNING DATES FROM 20060109 TO 20060322;REEL/FRAME:017743/0302

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION